ADNI Publications

ADNI Data and Publications Committee
Robert C. Green, MD, MPH - DPC Chair
Email: rcgreen@genetics.med.harvard.edu

Erin Drake - DPC Coordinator
Email: edrake@genetics.med.harvard.edu

Click here for the most recent review of all papers in ADNI.

View the ADNI Authorship list.

Year
Citation
Abstract
2014
Trzepacz PT, Yu P, Sun J, Schuh K, Case M, Witte MM, Hochstetler H, Hake A; Alzheimer's Disease Neuroimaging Initiative: Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Neurobiology of aging, 35(1):143-51, 2014.
 
2013
Adaszewski S, Dukart J, Kherif F, Frackowiak R, Draganski B; Alzheimer's Disease Neuroimaging Initiative. How early can we predict Alzheimer's disease using computational anatomy? Neurobiol Aging, 34(12):2815-26, 2013.
 
2013
Ayhan MS, Benton RG, Raghavan VV, Choubey S: Exploitation of 3D stereotactic surface projection for predictive modeling of Alzheimer's disease. Int J Data Min Bioinformatics, 7:146-165, 2013.
 
2013
Barnes J, Bartlett JW, Fox NC, Schott JM: Targeted recruitment using cerebrospinal fluid biomarkers: Implications for Alzheimer's disease therapeutic trials. Journal of Alzheimer's Disease, 34: 431-437, 2013.
 
2013
Boccardi M, Bocchetta M, Ganzola R, Robitaille N, Redolfi A, Duchesne S, Jack CR Jr, Frisoni GB, EADC-ADNI Working Group on the Harmonized Protocol for Hippocampal Volumetry and for the Alzheimer's Disease Neuroimaging Initiative: Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation. Alzheimer's & Dementia, Epub ahead of print, 2013.
 
2013
Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A; The Alzheimer Disease Neuroimaging Initiative, Morris MC, Evans DA, Johnson K, Sperling RA, Schneider JA, Bennett DA, De Jager PL: CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nature Neuroscience, 16: 848-850, 2013.
PMC3703870  View
2013
Brainerd CJ, Reyna VF, Gomes CF, Kenney AE, Gross CJ, Taub ES, Spreng RN; Alzheimer’s Disease Neuroimaging Initiative: Dual-Retrieval Models and Neurocognitive Impairment. J Exp Psychol Learn Mem Cogn., Epub, 2013.
 
2013
Bryant C, Giovanello KS, Ibrahim JG, Chang J, Shen D, Peterson BS, Zhu H; Alzheimer's Disease Neuroimaging Initiative: Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study. PLoS One, epub ahead of print, 2013.
PMC3756017  View
2013
Casanova R, Hsu FC, Sink KM, Rapp SR, Williamson JD, Resnick SM, Espeland MA; Alzheimer's Disease Neuroimaging Initiative: Alzheimer's disease risk assessment using large-scale machine learning methods. PLoS One, 8(11):e77949, 2013.
PMC3826736  View
2013
Cataldo R, Agrusti A, De Nunzio G, Carlà A, De Mitri I, Favetta M, Quarta M, Monno L, Rei L, Fiorina E; the Alzheimer’s Disease Neuroimaging Initiative: Generating a Minimal Set of Templates for the Hippocampal Region in MR Neuroimages. Journal of Neuroimaging, 23: 473-483, 2013.
 
2013
Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, Chibnik L, Bennett DA, Arnold SE, Harold D, Sims R, Gerrish A, Williams J, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Peskind ER, Galasko D, Fagan AM, Holtzman DM, Morris JC; GERAD Consortium; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Alzheimer Disease Genetic Consortium (ADGC), Goate AM: GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron, 78: 256-268, 2013.
PMC3664945  View
2013
Daianu M, Jahanshad N, Nir TM, Toga A, Jack CR, Weiner MW, Thompson P: Breakdown of Brain Connectivity between Normal Aging and Alzheimer's Disease: A Structural k-Core Network Analysis. Brain Connect, 3(4):407-22, 2013.
PMC3749712  View
2013
Delor I, Charoin JE, Gieschke R, Retout S, Jacqmin P: Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI. CPT Pharmacometrics Syst Pharmacol., Epub, 2013.
PMC3817374  View
2013
Derado G, Bowman FD, Zhang L: Predicting brain activity using a Bayesian spatial model. Statistical Methods in Medical Research, Aug;22(4):382-97, 2013.
 
2013
Diaz-de-Grenu LZ, Acosta-Cabronero J, Chong YF, Pereira JM, Sajjadi SA, Williams GB, Nestor PJ: A Brief History of Voxel-Based Grey Matter Analysis in Alzheimer's Disease. J Alzheimers Dis., 38(3):647-59, 2013.
 
2013
Dickerson BC, Wolk DA; Alzheimer's Disease Neuroimaging Initiative: Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau. Frontiers in Aging Neuroscience, Epub ahead of print, 2013.
PMC3795312  View
2013
Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA; Alzheimer Disease Neuroimaging Initiative: Regional Cortical Thinning Predicts Worsening Apathy and Hallucinations Across the Alzheimer Disease Spectrum. Am J Geriatr Psychiatry, Epub, 2013.
 
2013
Dukart J, Kherif F, Mueller K, Adaszewski S, Schroeter ML, Frackowiak RS, Draganski B; Alzheimer's Disease Neuroimaging Initiative: Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease. PLoS Comput Biol. 9(4):e1002987, 2013.
PMC3616972  View
2013
Dukart J, Mueller K, Barthel H, Villringer A, Sabri O, Schroeter ML, for the Alheimer's Disease Neuroimaging Initiative: Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI. Psychiatry Research, 212: 230-236, 2013.
 
2013
Fjell AM, Westlye LT, Grydeland H, Amlien I, Espeseth T, Reinvang I, Raz N, Holland D, Dale AM, Walhovd KB; Alzheimer Disease Neuroimaging Initiative: Critical ages in the life course of the adult brain: nonlinear subcortical aging. Neurobiology of Aging, 34:2239-2247, 2013.
PMC3706494  View
2013
Guo H, Song X, Vandorpe R, Zhang Y, Chen W, Zhang N, Schmidt MH, Rockwood K; for the Alzheimer’s Disease Neuroimaging Initiative: Evaluation of Common Structural Brain Changes in Aging and Alzheimer Disease with the Use of an MRI-Based Brain Atrophy and Lesion Index: A Comparison Between T1WI and T2WI at 1.5T and 3T. AJNR Am J Neuroradiol., Epub, 2013.
 
2013
Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R, Alzheimer's Disease Neuroimaging Initative: Brain size and the compensation of Alzheimer's disease symptoms: A longitudinal cohort study. Alzheimer's & Dementia, 9(5):580-6, 2013.
 
2013
Haight TJ, Landau SM, Carmichael O, Schwarz C, Decarli C, Jagust WJ, for the Alzheimer's Disease Neuroimaging Initiative: Dissociable effects of Alzeimer disease and white matter hyperintensitites on brain metabolism. JAMA Neurology,1;70(8):1039-45, 2013.
PMC3779687  View
2013
Hoang Duc AK, Modat M, Leung KK, Cardoso MJ, Barnes J, Kadir T, Ourselin S; Alzheimer’s Disease Neuroimaging Initiative: Using manifold learning for atlas selection in multi-atlas segmentation. PLoS One. 8(8):e70059, 2013.
PMC3732273  View
2013
Hohman TJ, Koran ME, Thornton-Wells TA; for the Alzheimer's Neuroimaging Initiative: Interactions between GSK3β and amyloid genes explain variance in amyloid burden. Neurobiol Aging, 35(3):460-5, 2013.
PMC3864626  View
2013
Hostage CA, Roy Choudhury K, Doraiswamy PM, Petrella JR, for the Alzheimer's Disease Neuroimaging Initiative:Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer's Disease. PLoS One, 8: e54483, 2013.
PMC3566140  View
2013
Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR Jr, Harvey D, Weiner MW, Thompson PM, the Alzheimer's Disease Neuroimaging Initiative: Unbiased tensor-based morphometry: Improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage, 66: 648-661, 2013.
PMC3785376  View
2013
Iglesias JE, Sabuncu MR, Van Leemput K, Alzheimer's Disease Neuroimaging Initiative: Improved inference in Bayesian segmentation using Monte Carlo sampling: Application to hippocampal subfield volumetry. Med Image Anal, 17: 766-778, 2013.
PMC3719857  View
2013
Jorge Cardoso M, Leung K, Modat M, Keihaninejad S, Cash D, Barnes J, Fox NC, Ourselin S; for the Alzheimer’s Disease Neuroimaging Initiative: STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Medical Image Analysis, 17: 671-684, 2013.
 
2013
Khondoker M, Dobson R, Skirrow C, Simmons A, Stahl D: A comparison of machine learning methods for classification using simulation with multiple real data examples from mental health studies. Stat Methods Med Res., Epub, 2013
 
2013
Kim S, Swaminathan S, Inlow M, Risacher SL, Nho K, Shen L, Foroud TM, Petersen RC, Aisen PS, Soares H, Toledo JB, Shaw LM, Trojanowski JQ, Weiner MW, McDonald BC, Farlow MR, Ghetti B, Saykin AJ, for the Alzheimer's Disease Neuroimaging Initiative: Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel. PLoS One, 8: e70269, 2013.
PMC3720913  View
2013
Kohannim O, Hua X, Rajagopalan P, Hibar DP, Jahanshad N, Grill JD, Apostolova LG, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative: Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clinical, 2:827-35, 2013.
PMC3777716  View
2013
Koran ME, Hohman TJ, Meda SA, Thornton-Wells TA: Genetic Interactions within Inositol-Related Pathways are Associated with Longitudinal Changes in Ventricle Size. J Alzheimers Dis., 38(1):145-54, 2013.
PMC3815519  View
2013
Koran ME, Hohman TJ, Thornton-Wells TA, for ADNI. Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography. Human Genetics, Epub ahead of print, 2013.
 
2013
Lampert EJ, Roy Choudhury K, Hostage CA, Petrella JR, Doraiswamy PM, Alzheimer's Disease Neuroimaging Initiative: Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives. PLoS One, 8: e60747, 2013.
PMC3629168  View
2013
Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WF, Mintun MA: Amyloid-B imaging with Pittsburgh compound B and florbetapir: Comparing radiotracers and quanitifcation methods: Journal of Nuclear Medicine, 54:70-77, 2013.
PMC3747730  View
2013
Liu CY, Iglesias JE, Tu Z, for the Alzheimer's Disease Neuroimaging Initiative: Deformable templates guided discriminative models for robust 3D brain MRI segmentation. Neuroinformatics, 11(4):447-68, 2013.
 
2013
Liu X, Tosun D, Weiner MW, Schuff N, Alzheimer's Disease Neuroimaging Initiative: Locally linear embedding (LLE) fro MRI based Alzheimer's disease classification. Neuroimage, 83C:148-157, 2013.
PMC3815961  View
2013
Llano DA, Devanarayan V, Simon AJ, The Alzheimer’s Disease Neuroimaging Initiative (ADNI): Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease. Alzheimer Disease and Associated Disorders,Jul-Sep;27(3):233-43, 2013.
 
2013
Lo RY, Jagust WJ; for the Alzheimer’s Disease Neuroimaging Initiative:Effect of Cognitive Reserve Markers on Alzheimer Pathologic Progression. Alzheimer Disease and Associated Disorders, 27(4):343-50, 2013.
PMC3745532  View
2013
Lorenzi M, Ayache N, Frisoni GB, Pennec X; for the Alzheimer's Disease Neuroimaging Initiative (ADNI): LCC-Demons: A robust and accurate diffeomorphic registration algorithm. Neuroimage,81C: 470-483, 2013.
 
2013
Mackin RS, Insel P, Tosun D, Mueller SG, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Lee JY, Jack CR Jr, Aisen PS, Petersen RC, Weiner MW; The Alzheimerʼs Disease Neuroimaging Initiative: The Effect of Subsyndromal Symptoms of Depression and White Matter Lesions on Disability for Individuals With Mild Cognitive Impairment. American Journal of Geriatric Psychiatry, Sep;21(9):906-14, 2013.
 
2013
Martinez-Mir A, Gonzalez-Perez A, Gayan J, Antunez C, Marin J, Boada M, Lopez-Arrieta JM, Fernandez E, Ramirez-Lorca R, Saez ME, Ruiz A, Scholl FG, Real LM: Genetic stufy of neurexin and neuroligin genes in Alzheimer's disease. Journal of Alzheimer's Disease, 35: 403-412, 2013.
 
2013
Mastaglia FL, Rojana-Udomsart A, James I, Needham M, Day TJ, Kiers L, Corbett JA, Saunders AM, Lutz MW, Roses AD; for the Alzheimer’s Disease Neuroimaging Initiative: Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms. Neuromuscul Disord., 23(12):969-74, 2013.
 
2013
Mattsson N, Insel P, Nosheny R, Zetterberg H, Trojanowski JQ, Shaw LM, Tosun D, Weiner M: CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders. Transl Psychiatry, Epub, 2013.
PMC3756294  View
2013
Meda SA, Koran ME, Pryweller JR, Vega JN, Thornton-Wells TA; Alzheimer's Disease Neuroimaging Initiative: Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative. Neurobiology of Aging, 34: 1518.e9-1518.e18, 2013.
PMC3570748  View
2013
Mukherjee S, Kim S, Ramanan VK, Gibbons LE, Nho K, Glymour MM, Ertekin-Taner N, Montine TJ, Saykin AJ, Crane PK; for the Alzheimer’s Disease Neuroimaging Initiative: Gene-based GWAS and biological pathway analysis of the resilience of executive functioning. Brain imagine and behavior, Epub ahead of print, 2013
 
2013
Nettiksimmons J, Beckett L, Schwarz C, Carmichael O, Fletcher E, DeCarli C, for the Alzheimer's Disease Neuroimaging Initiative: Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage. Psychology and Aging, 28:191-201, 2013.
PMC3751169  View
2013
Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS,Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA; for the Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; for the AddNeuroMed Consortium,McDonald BC, Farlow MR, Ghetti B; for the Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ: Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Molecular Psychiatry,18: 781-787, 2013.
PMC3777294  View
2013
Nir TM, Jahanshad N, Villalon-Reina JE, Toga AW, Jack CR, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (ADNI): Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clinical, 3:180-95, 2013.
PMC3792746  View
2013
Perneczky R, Alexopoulos P; for the; Alzheimer's Disease euroimaging Initiative: Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease. Alzheimer's & dementia, epub ahead of print, 2013.
 
2013
Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR Jr: Criteria for mild cognitive impairment due to alzheimer's disease in the community. Annals of Neurology, May 2013. Epub ahead of print.
PMC3804562  View
2013
Provenzano FA, Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, Guzman VA, Meier IB, Zimmerman ME, Brickman AM; for the Alzheimer's Disease Neuroimaging Initiative: White matter hyperintensities and cerebral amyloidosis: Necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurology, 70: 455-461, 2013.
 
2013
Rajagopalan P, Toga AW, Jack CR, Weiner MW, Thompson PM, for the Alzheimer's Disease Neuroimaging Initiative: Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. Neuroreport, 24:58-62, 2013.
PMC3635486  View
2013
Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust WJ, Weiner MW, Saykin AJ: APOE and BCHE as modulators of cerebral amyloid deposition: A florbetapir PET genome-wide association study. Mol Psychiatry, epub ahead of print, 2013.
PMC3661739  View
2013
Ribbens A, Hermans J, Maes F, Vandermeulen D, Suetens P: Unsupervised segmentation, clustering and groupwise registration of heterogeneous populations of brain MR images. IEEE Trans Med Imaging, Epub ahead of print, 2013.
 
2013
Ridge PG, Koop A, Maxwell TJ, Bailey MH, Swerdlow RH, Kauwe JS, Honea RA; Alzheimer’s Disease Neuroimaging Initiative: Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease. PLoS One, 8(9):e74158, 2013.
PMC3770576  View
2013
Rowley J, Fonov V, Wu O, Eskildsen SF, Schoemaker D, Wu L, Mohades S, Shin M, Sziklas V, Cheewakriengkrai L, Shmuel A, Dagher A, Gauthier S, Rosa-Neto P; for the Alzheimer's Disease Neuroimaging Initiative: White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer's Disease. PLoS One, Epub, 2013
PMC3785512  View
2013
Salas-Gonzalez D, Gorriz JM, Ramirez J, Padilla P, Illan IA: Improving the convergence rate in affine registration of PET and SPECT brain images using histogram equalization. Comput Math Methods Med, Epub ahead of print, 2013.
PMC3665226  View
2013
Samtani MN, Raghavan N, Shi Y, Novak G, Farnum M, Lobanov V, Schultz T, Yang E, DiBernardo A, Narayan VA; Alzheimer's Disease Neuroimaging Initiative: Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes.. British Journal of Clinical Pharmacology, 75:146-161, 2013.
PMC3555054  View
2013
Sanabria-Diaz G, Martínez-Montes E, Melie-Garcia L; Alzheimer’s Disease Neuroimaging Initiative: Glucose Metabolism during Resting State Reveals Abnormal Brain Networks Organization in the Alzheimer's Disease and Mild Cognitive Impairment. PLoS One. 8(7):e68860, 2013.
PMC3720883  View
2013
ShafferJL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Coleman RE, Doraiswamy PM, for the Alzheimer's Disease Neuroimaging Initiative: Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology, 266: 583-591, 2013.
PMC3558874  View
2013
Shen L, Thompson PM, Potkin SG, Bertram L, Farrer LA, Foroud TM, Green RC, Hu X, Huentelman MJ, Kim S, Kauwe JS, Li Q, Liu E, Macciardi F, Moore JH, Munsie L, Nho K, Ramanan VK, Risacher SL, Stone DJ, Swaminathan S, Toga AW, Weiner MW, Saykin AJ; for the Alzheimer’s Disease Neuroimaging Initiative: Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav., Epub, 2013.
 
2013
Sherva R, Tripodis Y, Bennett DA, Chibnik LB, Crane PK, de Jager PL, Farrer LA, Saykin AJ, Shulman JM, Green RC; The GENAROADS Consortium, and The Alzheimer's Disease Neuroimaging Initiative: Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimer's and Dementia, epub ahead of print, 2013.
PMC3760995  View
2013
Shi Y, Lai R, Toga A: Cortical Surface Reconstruction via Unified Reeb Analysis of Geometric and Topological Outliers in Magnetic Resonance Images. IEEE Trans Med Imaging, 32: 511-530, 2013.
PMC3785796  View
2013
Shokouhi S, Claassen D, Kang H, Ding Z, Roers B, Mishra A, Riddle WR, for the Alzheimer's Disease Neuroimaging Initiative: Longitudinal progression of cognitive decline correlates with changes in spatial pattern of brain 18F-FDG PET. Journal of Nuclear Medicine, 54(9):1564-9, 2013.
 
2013
Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, Roontiva A, McCabe C, Patsopoulos NA, Corneveaux JJ, Yu L, Huentelman MJ, Evans DA, Schneider JA, Reiman EM, De Jager PL, Bennett DA: Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurology,1;70(9):1150-7, 2013.
PMC3773291  View
2013
Song X, Mitnitski A, Zhang N, Chen W, Rockwood K, for the Alzheimer's Disease Neuroimaging Initiative: Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative. Journal of neurology, neurosurgery, and psychiatry, 84(1):71-8, 2013.
 
2013
Spreng RN, Turner GR: Structural covariance of the default network in healthy and pathological aging. J Neurosci., 33(38):15226-34, 2013.
PMC3776065  View
2013
Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust WJ, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, Petersen RC, Weiner MW, Saykin AJ, for the Alzheimer's Disease Neuroimaging Initiative: Association of plasma and cortical amyloid beta is modulated by APOE status. Alzheimer's & Dementia, 70: 386-401, 2013.
 
2013
Szigeti K, Lal D, Li Y, Doody RS, Wilhelmsen K, Yan L, Liu S, Ma C; Texas Alzheimer Research and Care Consortium: Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease. Journal of Alzheimer's Disease,33(2):517-23, 2013.
 
2013
Tamnes CK, Walhovd KB, Dale AM, Ostby Y, Grydeland H, Richardson G, Westlye LT, Roddey JC, Hagler DJ, Due-Tonnessen P, Holland D, Fjell AM, for the Alzheimer's Disease Neuroimaging Initiative: Brain development and aging: Overlapping and unique patterns of change. Neuroimage, 68:63-74, 2013.
 
2013
Thambisetty M, An Y, Nalls M, Sojkova J, Swaminathan S, Zhou Y, Singleton AB, Wong DF, Ferrucci L, Saykin AJ, Resnick SM, for the Baltimore Longitudinal Study of Aging and the Alzheimer's Disease Neuroimaging Initiative: Effect of complement CR1 on brain amyloid burden during aging and Its modification by APOE genotype. Biol Psychiatry, 73: 422-428, 2013.
PMC3535537  View
2013
Toledo JB, Korff A, Shaw LM, Trojanowski JQ, Zhang J: CSF a-Synuclein improves diagnostic and prognostic performance of tau and AB in Alzheimer's disease. Acta Neuropathol, 126(5):683-97, 2013.
PMC3812407  View
2013
Toledo JB, Xie SX, Trojanowski JQ, Shaw LM: Longitudinal change in CSF Tau and AB biomarkers for up to 48 months in ADNI. Acta Neuropathol, 126(5):659-70, 2013.
 
2013
Trzepacz PT, Saykin A, Yu P, Bhamditipati P, Sun J, Dennehy EB, Willis B, Cummings JL; Alzheimer's Disease Neuroimaging Intiative: Subscale validation of the neuropsychiatric inventory questionnaire: Comparison of Alzheimer's Disease Neuroimaging Initiative and National Alzheimer's Coordinating Center Cohorts. The American Journal of Geriatric Psychiatry, 21: 607-622, 2013.
 
2013
Vidoni ED, Morris JK, Raider K, Burns JM; Alzheimer’s Disease Neuroimaging Initiative: Reducing post-lumbar puncture headaches with small bore atraumatic needles. Journal of Clinical Neuroscience, Epub ahead of print, 2013.
 
2013
Wang Z, Das SR, Xie SX, Arnold SE, Detre JA, Wolk DA; Alzheimer's Disease Neuroimaging Initiative: Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study. Neuroimage Clinical, 2:630-6, 2013.
PMC3777751  View
2013
Westman E, Aguilar C, Muehlboeck JS, Simmons A: Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer's Disease and Mild Cognitive Impairment. Brain Topography, 26:9-23, 2013.
PMC3536978  View
2013
Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K: The receiver operational characteristic for binary classification with multiple indices and its application to the Neuroimaging Study of Alzheimer's Disease. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 10: 173-180, 2013.
 
2013
Wyman BT, Harvey DJ, Crawford K, Bernstein MA, Carmichael O, Cole PE, Crane PK, Decarli C, Fox NC, Gunter JL, Hill D, Killiany RJ, Pachai C, Schwarz AJ, Schuff N, Senjem ML, Suhy J, Thompson PM, Weiner M, Jack CR Jr, Alzheimer’s Disease Neuroimaging Initiative: Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimer's & Dementia, 9: 332-337, 2013.
 
2013
Xu XS, Samtani MN, Dunne A, Nandy P, Vermeulen A, De Ridder F; The Alzheimer’s Disease Neuroimaging Initiative: Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries. Journal of Pharmacokinetics and Pharmacodynamics,40(4):537-44, 2013.
 
2013
Young J, Modat M, Cardoso MJ, Mendelson A, Cash D, Ourselin S; Alzheimer's Disease Neuroimaging Initiative: Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neuroimage Clinical, 2:735-45, 2013.
PMC3777690  View
2013
Yu P, Wolz R, Stephenson D, Brewer J, Fox NC, Cole PE, Jack CR, Hill DLG, Schwarz AJ, for the Coalition Against Major Diseases and the Alzheimer's Disease Neuroimaging Initiative: Operationalizing hippocampal volume as an enrichment biomarker for amnestic MCI trials: effect of algorithm, test-retest variability and cut-point on trial cost, duration and sample size. Neurobiology of Aging, In press, 2013.
 
2013
Zahodne LB, Gongvatana A, Cohen RA, Ott BR, Tremont G, Alzheimer's Disease Neuroimaging Initiative: Are apathy and depression independently associated with longitudinal trajectories of mild cognitive impairment? American Journal of Geriatric Psychiatry, 21(11):1098-1106, 2013.
PMC3797189  View
2013
Zhou J, Liu J, Narayan VA, Ye J; for the Alzheimer's Disease Neuroimaging Initiative: Modeling disease progression via multi-task learning. Neuroimage, 78: 233-248, 2013.
 
2012
Arnold SE, Xie SX, Leung YY, Wang LS, Kling MA, Han X, Kim EJ, Wolk DA, Bennett DA, Chen-Plotkin A, Grossman M, Hu W, Lee VM, Mackin RS, Trojanowski JQ, Wilson RS, Shaw LM: Plasma biomarkers of depressive symptoms in older adults. Translational Psychiatry, 2:e65, 2012.
PMC3309547  View
2012
Augustinack JC, Huber KE, Stevens AA, Roy M, Frosch MP, van der Kouwe AJ, Wald LL, Van Leemput K, McKee AC, Fischl B, For the Alzheimer's Disease Neuroimaging Initiative: Predicting the location of human perirhinal cortex, Brodmann's area 35, from MRI. NeuroImage, 64C:32-42, 2012.
PMC3508349  View
2012
Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM; for the Alzheimer's Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition, and Genetics Study: Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. PNAS, 109:3985-3990, 2012.
PMC3309762  View
2012
Boccardi M, Bocchetta M, Ganzola R, Robitaille N, Redolfi A, Duchesne S, Jack CR Jr, Frisoni GB; EADC-ADNI Working Group on The Harmonized Protocol for Hippocampal Volumetry and for the Alzheimer's Disease Neuroimaging Initiative: Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation. Alzheimers & Dementia, May 2013. Epub ahead of print.
 
2012
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC,Salvado O, Macaulay SL, Masters CL, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle StudyResearch Group: A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Molecular Psychiatry, April 2013. Epub ahead of print.
 
2012
Carmichael O, McLaren DG, Tommet D, Mungas D, Jones RN, for the Alzheimer's Disease Neuroimaging Initiative: Coevoluation of brain structures in amnestic mild cognitive impairment. NeuroImage, 66C:449-456, 2012.
PMC3593811  View
2012
Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB; and the EADC-PET Consortium, NEST-DD, and Alzheimer's Disease Neuroimaging Initiative: Summary Metrics to Assess Alzheimer Disease-Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison. Journal of nuclear medicine. 53:592-600, 2012.
PMC3640308  View
2012
Casanova R, Hsu FC; Mark A. Espeland, for the Alzheimer's Disease Neuroimaging Initiative: Classification of structural MRI images in Alzheimer's disease from the perspective of ill-posed problems. PLoS One, 7: e44877, 2012.
PMC3468621  View
2012
Cedarbaum JM, Jaros M, Hernandez C, Coley N, Andrieu S, Grundman M, Vellas B, Alzheimer's Disease Neuroimaging Initiative: Rationale for Use of the Clinical Dementia Rating Sum of Boxes (CDR-SB) as a Primary Outcome Measure for Alzheimer’s Disease Clinical Trials. Alzheimer’s & Dementia, 9: S45-S55, 2013.
 
2012
Chincarini A, Bosco P, Gemme G, Esposito M, Rei L, Squarcia S, Bellotti R, Minthon L, Frisoni G, Scheltens P, Frölich L, Soininen H, Visser PJ, Nobili F; Alzheimer's Disease Neuroimaging Initiative: Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study. Alzheimer's & dementia, Epub ahead of print, 2013.
 
2012
Cho Y, Seong JK, Jeong Y, Shin SY; for the Alzheimer's Disease Neuroimaging Initiative: Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data. Neuroimage. 59:2217-2230, 2012.
 
2012
Chu C, Hsu AL, Chou KH, Bandettini P, Lin CP; for the Alzheimer's Disease Neuroimaging Initiative: Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage, 60:59-70, 2011.
 
2012
Coubard OA, for the Alzheimer's Disease Neuroimaging Initiative: A method for processing multivariate data in medical studies. Statistics in Medicine, 10;32(20):3436-48, 2013.
PMC3744618  View
2012
Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, Jones RN, Mukherjee S, Curtis SM, Harvey D, Weiner M, Mungas D, for the Alzheimer’s Disease Neuroimaging Initiative: Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Brain Imaging and Behavior, 6:502-516, 2012
PMC3806057  View
2012
Cruchaga C, Kauwe JS, Nowotny P, Bales K, Pickering EH, Mayo K, Bertelsen S, Hinrichs A; the Alzheimer's Disease Neuroimaging Initiative, Fagan AM, Holtzman DM, Morris JC, Goate AM: Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Human Molecular Genetics, 21:4558-4571, 2012.
PMC3459471  View
2012
Cuingnet R, Glaunès JA, Chupin M, Benali H, Colliot O: Spatial and Anatomical Regularization of SVM: A General Framework for Neuroimaging Data. IEEE transactions on pattern analysis and machine intelligence, Epub ahead of print, 2012.
 
2012
Damoiseaux JS, Seeley WW, Zhou J, Shirer WR, Coppola G, Karydas A, Rosen HJ, Miller BL, Kramer JH, Greicius MD, Alzheimer's Disease Neuroimaging Initiative: Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. The Journal of Neuroscience, 32:8254-8262, 2012.
PMC3394933  View
2012
Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM, for the Alzheimer's Disease Neuroimaging Initiative: Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau. Archives of Neurology, 69:709-713, 2012.
PMC3423526  View
2012
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN, for the Alzheimer's Disease Neuroimaging Initiative and Australian Imaging Biomarker and Lifestyle Research Group: Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease. Archives of Neurology, 16:1-8, 2012.
 
2012
Domoto-Reilly K, Sapolsky D, Brickhouse M, Dickerson BC, for the Alzheimer's Disease Neuroimaging Initiative: Naming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophy. NeuroImage, 63:348-355, 2012.
PMC3665400  View
2012
Edo Richard, Ben A Schmand, Piet Eikelenboom, Willem A Van Gool, The Alzheimer's Disease Neuroimaging Initiative: "MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer’s disease in patients with mild cognitive impairment: a diagnostic accuracy study." BMJ Open 2013;3:e002541, April 2013.
 
2012
Epstein NU, Xie H, Ruland SD, Pandey DK, for the Alzheimer's Disease Neuroimaging Initiative: Vascular risk factors and cardiovascular outcomes in the Alzheimer's Disease Neuroimaging Initiative. American Journal of Alzheimer's Disease & Other Dementias. 27:275-279, 2012.
 
2012
Escudero J, Ifeachor E, Zajicek JP: Bioprofile Analysis: A New Approach for the Analysis of Biomedical Data in Alzheimer's Disease. Journal of Alzheimer’s Disease, 32:997-1010, 2012.
 
2012
Gray KR, Aljabar P, Heckemann RA, Hammers A, Rueckert D, for the Alzheimer's Disease Neuroimaging Initiative: Random forest-based similarity measures for multi-modal classification of Alzheimer's disease. NeuroImage, 65:167-175, 2012.
PMC3516432  View
2012
Gray KR, Wolz R, Heckemann RA, Aljabara P, Hammers A, Rueckert D; for the Alzheimer's Disease Neuroimaging Initiative: Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease. Neuroimage, 60:221-229, 2012
PMC3303084  View
2012
Greene SJ, Killiany RJ; The Alzheimer's Disease Neuroimaging Initiative: Hippocampal Subregions are Differentially Affected in the Progression to Alzheimer's Disease. Anatomical Record, 295(1):132-140, 2012.
 
2012
Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O,Cummings JL, Thompson PL, Elashoff D, Alzheimer's Disease Neuroimaging Initiative: Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiology of Aging, 34:62-72, 2012.
PMC3412892  View
2012
Gross AL, Inouye SK, Rehok GW, Brandt J, Crane PK, Parisi JM, Tommet D, Bandeen-Roche K, Carlson MC, Jones RN, for the Alzheimer's Disease Neuroimaging Initiative: Parallel but not equivalent: Challenges and solutions for repeated assessment of cognition over time. Journal of Clinical and Experimental Neuropsychology, 34:758-772, 2012.
 
2012
Gross AL, Manly JJ, Pa J, Johnson JK, Park LQ, Mitchell MB, Melrose RJ, Inouye SK, McLaren DG, for the Alzheimer’s Disease Neuroimaging Initiative: Cortical signatures of cognition and their relationship to Alzheimer's disease. Brain Imaging and Behavior, 6:584-598, 2012.
PMC3553578  View
2012
Guo LH, Alexopoulos P, Perneczky R: Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience, 263(7):553-560, 2013.
 
2012
Gutman BA, Hua X, Rajagopalan P, Chou YY, Wang Y, Yanovsky I, Toga AW, Jack CR Jr, Weiner MW, Thompson PM, for the Alzhiemer's Disease Neuroimaging Initiative: Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features. Neuroimage, 70:386-401, 2013.
 
2012
Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM; Alzheimer's Disease Neuroimaging Initiative: White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Epub Ahead of Print 2013
PMC3663926  View
2012
Habeck C, Risacher S, Lee GL, Glymour MM, Mormino E, Mukherjee S, Kim S, Nho K, DeCarli C, Saykin A, Crane P, for the Alzheimer's Disease Neuroimaging Initiative: Relationship between baseline brain metabolism measured using [(18)F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging and Behavior, 6:568-583, 2012.
PMC3532575  View
2012
Haight TJ, Jagust WJ, for the Alzheimer's Disease Neuroimaging Initiative: Relative contributions of biomarkers in Alzheimer's disease. Annals of Epidemiology, 22:868-875, 2012.
PMC3510749  View
2012
Han SD, Gruhl J, Beckett L, Dodge HH, Stricker NH, Farias S, Mungas D, for the Alzheimer’s Disease Neuroimaging Initiative: Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease. Brain Imaging and Behavior,6:610-620, 2012
PMC3582336  View
2012
Harrison TM, Weintraub S, Mesulam M-M, Rogalski E: Superior memory and higher cortical volumes in unusually successful cognitive aging. Journal of the International Neuropsychological Society, 1-5, 2012.
PMC3457607  View
2012
Henley DB, Sundell KL, Sethuraman G, Siemers ER, Alzheimer's Disease Neuroimaging Initiative: Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies. Alzheimer's and Dementia, 8:407-416, 2012.
 
2012
Hobart J, Cano S, Posner H, Selnes O, Stern Y, Thomas R, Zajicek J; Alzheimer's Disease Neuroimaging Initiative: Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods. Alzheimers Dement. Epub, 2012.
 
2012
Holland D, Desikan RS, Dale AM, McEvoy LK, for the Alzheimer’s Disease Neuroimaging Initiative: Rates of Decline in Alzheimer Disease Decrease with Age. PloS One, 7:e42325, 2012.
PMC3410919  View
2012
Holland D, McEvoy LK, Desikan RS, Dale AM, for the Alzheimer's Diseaes Neuroimaging Initiative: Enrichment and stratification for predementia Alzheimer disease clinical trials. PLoS One, 7:e47739, 2012.
 
2012
Honea RA, Vidoni ED, Swerdlow RH, Burns JM: Maternal Family History is Associated with Alzheimer's Disease Biomarkers. Journal of Alzheimer’s Disease, 31:659-668.
PMC3608420  View
2012
Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Sideowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H, Alzheimer's Disease Neuroimaging Initiative: Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology, 79:897-905, 2012.
PMC3425844  View
2012
Ito K, Hutmacher MM, Corrigan BW: Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database. Journal of Pharmacokinetics and Pharmacodynamics, 39:601-618, 2012.
 
2012
Jedynak BM, Lang A, Liu B, Katz E, Zhang Y, Wyman BT, Raunig D, Jedynak CP, Caffo B, Prince JL, for the Alzheimer's Disease Neuroimaging Initiative: A computational neurodegernartive disease progression score: Method and results with the Alzheimer's Disease Neuroimaging Initiative cohort. Neuroimage, 63:1478-1486, 2012.
PMC3472161  View
2012
Johnson JK, Gross AL, Pa J, McLaren DG, Park LQ, Manly JJ, for the Alzheimer's Disease Neuroimaging Initiative: Longitudinal change in neuropsychological performance using latent growth models: A study of mild cognitive impairment. Brain Imaging Behav, 6:540-550, 2012.
PMC3532521  View
2012
Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; The Alzheimer's Disease Neuroimaging Initiative, Sweet RA, Feingold E, Dekosky ST, Lopez OL: Genome-wide association analysis of age-at-onset in Alzheimer's disease. Molecular Psychiatry, 17:1340-1346, 2012.
PMC3262952  View
2012
Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative, Jun G, Baldwin C, Logue MW, Buros J, Farrer L, Pericak-Vance MA, Haines JL, Sweet RA, Ganguli M, Feingold E, Dekosky ST, Lopez OL, Barmada MM: Genome-wide association study of Alzheimer's disease. Translational Psychiatry, 2:e117, 2012.
 
2012
Kawashima S, Ito K, Kato T; the SEAD-J Study Group: Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies. BMJ Open. 2:e000773, 2012.
PMC3341597  View
2012
Keator DB, Fallon JH, Lakatos A, Fowlkes CC, Potkin SG, Ihler A, for the Alzheimer's Disease Neuroimaging Initiative: Feed-forward hierarchical model of the ventral visual stream applied to functional brain image classification. Human Brain Mapping, Epub ahead of print, 2012.
 
2012
Khan AF, Drozd JJ, Moreland RK, Ta RM, Borrie MJ, Bartha R, and the Alzheimer's Disease Neuroimaging Initiative: A novel MRI-compatible brain ventricle phantom for validation of segmentation and volumetry methods. Journal of Magnetic Resonance Imaging, 36:476-482, 2012.
 
2012
Kiddle SJ, Thambisetty M, Simmons A, Riddoch-Contreras J, Hye A, Westman E, Pike I, Ward M, Johnston C, Lupton MK, Lunnon K, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Mecocci P, Lovestone S, Newhouse S, Dobson R, for the Alzheimers Disease Neuroimaging Initiative: Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden. PLoS One, 7:e44260, 2012.
PMC3454385  View
2012
Kohannim O, Hibar DP, Stein JL, Jahanshad N, Hua X, Rajagopalan P, Toga AW, Jack CR Jr, Weiner MW, de Zubicaray GI, McMahon KL, Hansell NK, Martin NG, Wright MJ, Thompson PM, Alzheimer's Disease Neuroimaging Initiative: Discovery and replication of gene influences on brain structure using LASSO regression. Frontiers in Neuroscience, 6:115, 2012.
PMC3412288  View
2012
Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ, for the Alzheimer's Disease Neuroimaging Initiative: Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of neurology, 72:578-586, 2012.
PMC3786871  View
2012
Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative: Annals of Neurology, March 2013 ( epub ahead of print)
PMC3748164  View
2012
Lehmann M, Koedam EL, Barnes J. Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC, Alzheimer's Disease Neuroimaging Initiative: Visual Ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers. Neurobiology of Aging, 34:73-82, 2012.
 
2012
Leung KK, Ridgway GR, Ourselin S, Fox NC; The Alzheimer's Disease Neuroimaging Initiative: Consistent multi-time-point brain atrophy estimation from the boundary shift integral. Neuroimage, 59:3995-4005, 2012.
 
2012
Liu Y, Mattila J, Ruiz MÁ, Paajanen T, Koikkalainen J, van Gils M, Herukka SK, Waldemar G, Lötjönen J, Soininen H; for the Alzheimer’s Disease Neuroimaging Initiative: Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool. PLoS One 8:e55246, 2013
PMC3570420  View
2012
Lo RY, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative: Vascular burden and Alzheimer disease pathologic progression. Neurology, 79:1349-1355, 2012.
PMC3448744  View
2012
Lourdusamy A, Newhouse S, Lunnon K, Proitsi P, Powell J, Hodges A, Nelson SK, Stewart A, Williams S, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Lovestone S; on behalf of the AddNeuroMed Consortium, Dobson R; for the Alzheimer’s Disease Neuroimaging Initiative: Identification of cis- regulatory variation influencing protein abundance levels in human plasma. Human molecular genetics, 21:3719-3726, 2012.
 
2012
Macdonald KE, Bartlett JW, Leung KK, Ourselin S, Barnes J, for the ADNI investigators: The value of hippocampal and temporal horn volumes and atrophy rates in predicting future conversion to AD. Alzheimer Disease & Associated Disorders, 27: 168-173, 2013.
 
2012
Maldjian JA, Whitlow CT: Whither the Hippocampus? FDG PET Hippocampal Hypometabolism in Alzheimer's Disease Revisited. American Journal of Neuroradiology, 33:1975-1982, 2012.
 
2012
Melville SA, Buros J, Parrado AR, Vardarajan B, Logue MW, Shen L, Risacher SL, Kim S, Jun G, DeCarli C, Lunetta KL, Baldwin CT, Saykin AJ, Farrer LA, Alzheimer's Disease Neuroimaging Initiative: Multiple loci influencing hippocampal degeneration identified by genome scan. Annals of neurology, 72:65-75, 2012.
PMC3405172  View
2012
Mouiha A, Duchesne S: Toward a dynamic biomarker model in Alzheimer's disease. Journal of Alzheimer's Disease, 30:91-100, 2012
 
2012
Mukherjee S, Kim S, Gibbons LE, Nho K, Risacher SL, Glymour MM, Habeck C, Lee GL, Mormino E, Ertekin-Taner N, Montine TJ, Decarli C, Saykin AJ, Crane PK, for the Alzheimer's Disease Neuroimaging Initiative: Genetic architecture of resilience of executive functioning. Brain Imaging Behavior, 6:621-633, 2012.
PMC3607298  View
2012
Murphy EA, Roddey JC, McEvoy LK, Holland D, Hagler DJ Jr, Dale AM, Brewer JB, Alzheimer's Disease Neuroimaging Initiative: CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Brain Imaging Behavior, 6:16-26, 2012.
 
2012
Nestor SM, Gibson E, Gao FQ, Kiss A, Black SE, for the Alzheimer's Disease Neuroimaging Initiative: A Direct Morphometric Comparison of Five Labeling Protocols for Multi-Atlas Driven Automatic Segmentation of the Hippocampus in Alzheimer's Disease. NeuroImage, 66C:50-70, 2012.
PMC3606906  View
2012
Nho K, Risacher SL, Crane PK, Decarli C, Glymour MM, Habeck C, Kim S, Lee GJ, Mormino E, Mukherjee S, Shen L, West JD, Saykin AJ, Alzheimer’s Disease Neuroimaging Initiative (ADNI): Voxel and surface-based topography and memory of executive deficits in mild cognitive impairment and Alzheimer's disease. Brain imaging and behavior, 6:551-567, 2012.
PMC3532574  View
2012
Padilla P, Gorriz J, Ramirez J, Salas-Gonzalez D, Illan I: NMF-SVM Based CAD Tool Applied to Functional Brain Images for the Diagnosis of Alzheimer's Disease, IEEE Trans Med Imaging. 31:207-16, 2011.
 
2012
Pardoe HR, Abbott DF, Jackson GD, The Alzheimer's Disease Neuroimaging Initiative: Sample size estimates for well-powered cross-sectional cortical thickness studies. Human Brain Mapping, 34(11):3000-9, 2012.
PMC3500581  View
2012
Park H, ADNI: ISOMAP induced manifold embedding and its application to Alzheimer's disease and mild cognitive impairment. Neuroscience Letters, 513:141-145, 2012.
 
2012
Park H; the ADNI: ISOMAP induced manifold embedding and its application to Alzheimer's disease and mild cognitive impairment. Neuroscience letters, 513:141-145, 2012.
 
2012
Posner HB, Cano S, Carrillo MC, Selnes O, Stern Y, Thomas RG, Zajicek J, Hobart J; for the Alzheimer's Disease Neuroimaging Initiative:Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: A new approach. Alzheimer's and Dementia, 9:S56-60, 2013
 
2012
Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust WJ, Frisoni GB; Translational Outpatient Memory Clinic Working Group; for the Alzheimer's Disease Neuroimaging Initiative:Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Epub ahead of print 2013
 
2012
Rajagopalan P, Jahanshad N, Stein JL, Hua X, Madsen SK, Kohannim O, Hibar DP, Toga AW, Jack CR Jr, Saykin AJ, Green RC, Weiner MW, Bis JC, Kuller LH, Riverol M, Becker JT, Lopez OL, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (ADNI); Cardiovascular Health Study (CHS): Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. Neuroimage Clinical, 1(1):179-87, 2012.
PMC3757723  View
2012
Ramakers IH, Verhey FR, Scheltens P, Hampel H, Soininen H, Aalten P, Rikkert MO, Verbeek MM, Spiru L, Blennow K, Trojanowski JQ, Shaw LM, Visser PJ, The Alzheimer’s Disease Neuroimaging Initiative and DESCRIPA Investigators: Anxiety is related to Alzheimer’s disease markers in cerebrospinal fluid of subjects with mild cognitive impairment. Psychological Medicine, 7:1-10, 2012.
 
2012
Rasmussen JM, Lakatos A, van Erp TG, Kruggel F, Keator DB, Fallon JT, Macciardi F, Potkin SG; Alzheimer's Disease Neuroimaging Initiative: Empirical derivation of the reference region for computing diagnostic sensitive (18)fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample. Biochimica et Biophysica acta, 1822:457-66, 2011
 
2012
Reiner P, Jouvent E, Duchesnay E, Cuingnet R, Mangin JF, Chabriat H: Sulcal Span in Azheimer's Disease, Amnestic Mild Cognitive Impairment, and Healthy Controls. Journal of Alzheimer's Disease. 29:605-613, 2012.
 
2012
Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen TC, Jack CR Jr, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, and Saykin AJ, for the Alzheimer's Disease Neuroimaging Initiative: The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Frontiers in Aging Neuroscience, 5:1-12, 2013.
PMC3612590  View
2012
Robitaille N, Mouiha A, Crepeault B, Valdivia F, Duchesne S, the Alzheimer's Disease Neuroimaging Initiative: Tissue-based MRI intensity standardization: Application to multicentric datasets. International Journal of Biomedical Imaging, epub ahead of print, 2012.
PMC3352580  View
2012
Rogers JA, Polhamus D, Gillespie WR, Ito K, Romero K, Qiu R, Stephenson D, Gastonguay MR, et al: Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: A beta regression meta-analysis. Journal of Pharmacokinetics & Pharmacodynamics, epub ahead of print, 2012
 
2012
Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; and the ADNI: A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: Replication in elderly and young populations. Epub Ahead of Print 2013
 
2012
Schmand B, Eikelenboom P, van Gool WA: Value of Diagnostic tests to Predict Conversion to Alzheimer's Disease in Young and Old Patients with Amnestic Mild Cognitive Impairment. Journal of Alzheimer's Disease, 29:641-648, 2012.
 
2012
Schott JM, Adni Investigators. Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging, 33:1486.e9-1486.e15, 2012.
PMC3150628  View
2012
Shi J, Thompson PM, Gutman B, Wang Y, for the Alzheimer's Disease Neuroimaging Initiative: Surface fluid registration of conformal representation: Application to detect disease effects and genetic influence on hippocampus. NeuroImage, in press.
PMC3683848  View
2012
Silver M, Janousova E, Hua X, Thompson PM, Montana G, The Alzheimer's Disease Neuroimaging Initiative: Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression. NeuroImage, 63:1681-1694, 2012.
PMC3549495  View
2012
Simonsen AH, Mattila J, Hejl AM, Frederiksen KS, Herukka SK, Hallikainen M, van Gils M, Lotjonen J, Soininen H, Waldemar G: Application of the PredictAD software tool to predict progression in patients with mild cognitive impairment. Dementia and Geriatric Cognitive Disordorders, 34:344-350, 2012.
 
2012
Singh N, Wang AY, Sankaranarayanan P, Fletcher PT, Joshi S, Alzheimer's Disease Neuroimaging Initiative: Genetic, structural and functional imaging biomarkers for early detection of conversion from MCI to AD. Medical Imaging Computing and Computer-Assisted Intervention, 15:132-140, 2012.
 
2012
Skinner J, Carvalho JO, Potter GG, Thames A, Zelinski E, Crane PK, Gibbons LE; for the Alzheimer’s Disease Neuroimaging Initiative: The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI. Brain imaging and behavior, 6:489-501, 2012.
 
2012
Skup M, Zhu H, Zhang H: Multiscale adaptive marginal analysis of longitudinal neuroimaging data with time-varying covariates. Biometrics,68:1083-1092, 2012.
PMC3767131  View
2012
Smith CD, Andersen AH, Gold BT: Structural brain alterations before mild cognitive impairment in ADNI: Validation of volume loss in a predefined antero-temporal region. Journal of Alzheimer's Disease, 31:S49-58, 2012.
PMC3652624  View
2012
Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust WJ; for the Alzheimer’s Disease Neuroimaging Initiative: CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain imaging and behavior, 6:599-609, 2012.
PMC3656503  View
2012
Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, Foroud T, Mayeux R, Shen L, Kim S, Turk M, Hardy J, Reiman EM, Saykin AJ, for the Alzheimer's Disease Neuroimaging Initiative and the NIA-LOAD/NCRAD Family Study Group: Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. PLOS One, 7, e50640, 2012.
PMC3515604  View
2012
Toussaint PJ, Perlbarg V, Bellec P, Desarnaud S, Lacomblez L, Doyon J, Habert MO, Benali H; for the Alzheimer's Disease Neuroimaging Initiative: Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses. Neuroimage, 63:936-946, 2012.
 
2012
Trzepacz PT, Yu P, Bhamidipati PK, Willis B, Forrester T, Tabas L, Schwarz AJ, Sayking AJ, for the Alzheimer's Disease Neuroimaging Initiative: Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease. Alzheimer's and Dementia, epub ahead of print, 2012.
 
2012
Üstünkar G, Özögür-Akyüz S, Weber GW, Friedrich CM und Son YA: Selection of Representative SNP Sets for Genome-Wide Association Studies: A Metaheuristic Approach. Optimization Letters, 6:1207-1218, 2012.
 
2012
Wadsworth LP, Lorius N, Donovan NJ, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA, for the Alzheimer's Disease Neuroimaging Initiative: Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dementia and Geriatric Cognitive Disorders, 34:96-111, 2012.
PMC3549662  View
2012
Wang H, Nie F, Huang H, Risacher SL, Saykin AJ, Shen L, for the Alzheimer's Disease Neuroimaging Initiative: Identifying disease sensitive and quantitative trait relevant biomarkers from heterogeneous imaging genetics data via sparse multi-modal multi-task learning. Bioinformatics, 28:127-136, 2012.
PMC3371860  View
2012
Wang H, Nie F, Huang H, Yan J, Kim S, Nho K, Risacher SL, Saykin AJ, Shen L, For the Alzheimer's Disease Neuroimaging Initiative: From phenotype to genotype: An association study of longitudinal phenotypic markers to Alzheimer's disease relelvant SNPs. Bioinformatics, 28:127-136, 2012
PMC3436838  View
2012
Wee CY, Yap PT, Shen D, for the Alzheimer's Disease Neuroimaging Initiative: Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns. Human Brain Mapping, 34(12):3411-25, 2013.
PMC3511623  View
2012
Westman E, Muehlboeck JS, Simmons A: Combinging MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimaging, 62:229-238, 2012.
 
2012
Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, Boeve BF, Petersen RC, Jack CR, Alzheimer Disease Neuroimaging Initiative FT: Comparison of imaging biomarkers in the Alzheimer disease neuroimaging initiative and the mayo clinic study of aging. Archives of Neurology, 69:614-622, 2012.
PMC3569033  View
2012
Wu L, Rowley J, Mohades S, Leuzy A, Dauar MT, Shin M, Fonov V, Jia J, Gauthier S, Rosa-Neto P, the Alzheimer’s Disease Neuroimaging Initiative: Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment. PLoS One, 7:e47905, 2012.
PMC3480449  View
2012
Yang HD, Yang YS, Legesse BT, Kim SY, for the Alzheimer's Disease Neuroimaging Initiative: Subtypes of amnestic mild cognitive impairment based on memory impairment pattern and its potential clinical significance. Dementia and Neurocognitive Disorders. 11:59-66, 2012.
 
2012
Yang X, Tan MZ, Qiu A, the Alzheimer's Disease Neuroimaging Initiative: CSF and brain structural imaging markers of the Alzheimer's pathological cascade. PLoS One, 7:e47406, 2012.
PMC3526616  View
2012
Yuan L, Wang Y, Thompson PM, Narayan VA, YeJ, for the Alzheimer's Disease Neuroimaging Initiative: Multi-source feature learning for join analysis of incomplete multiple heterogeneous neuroimaging. Neuroimage, 61:622-632, 2012.
PMC3358419  View
2012
Zhang N, Song X, Zhang Y, Alzheimer's Disease Neuroimaging Initiative: Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 33:318-326, 2012.
PMC3490129  View
2012
Zhou B, Nakatani E, Teramukai S, Nagai Y, Fukushima M: Risk classification in mild cognitive impairment patients for developing Alzheimer's disease. Journal of Alzheimer's Disease, 30:367-375, 2012.
 
2012
Ziegler G, Dahnke R, Gaser C; The Alzheimer’s Disease Neuroimaging Initiative: Models of the Aging Brain Structure and Individual Decline. Fronteirs in Neuroinformatics,6:3, 2012.
PMC3303090  View
2011
Abdulkadir A, Mortamet B, Vemuri P, Jack CR Jr, Krueger G, Kloopel S, The Alzheimer's Disease Neuroimaging Initiative: Effects of hardware heterogeneity on the performance of SVM Alzheimer's disease classifier. Neuroimage, 58:785-792, 2011.
PMC3258661  View
2011
Aksu Y, Miller DJ, Kesidis G, Bigler DC, Yang QX: An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients. PLoS one, 6:e25074, 2011.
PMC3192038   View
2011
Alexopoulos P, Guo LH, Kratzer M, Westerteicher C, Kurz A, Perneczky R: Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer's Disease Cerebrospinal Fluid Markers. Dementia and Geriatric Cognitive Disorders, 32:164-170, 2011.
PMC3696367  View
2011
Antunez C, Boada M, Gonzalez-Perez A, Gayan J, Ramirez-Lorca R, Marin J, Hernandez I, Moreno-Rey C, Moron FJ, Lopez-Arrieta J, Mauleon A, Rosende-Roca M, Noguera-Perea F, Legaz-Garcia A, Vivancos-Moreau L, Velasco J, Carrasco JM, Alegret M, Antequera-Torres M, Manzanares S, Romo A, Blanca I, Ruiz S, Espinosa A, Castano S, Garcia B, Martinez-Herrada B, Vinyes G, Lafuente A, Becker JT, Galan JJ, Serrano-Rios M; The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's Disease. Genome Med. 3:33, 2011.
PMC3219074  View
2011
Antunez C, Boada M, Lopez-Arrieta J, Moreno-Rey C, Hernandez I, Marin J, Gayan J, Alzheimer's Disease Neuroimaging Initiative, Gonzalez-Perez A, Real LM, Alegret M, Tarraga L, Ramirez-Lorca R, Ruiz A: Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease. Alzheimer's Dementia, 7:e124-e129, 2011.
 
2011
Bakken TE, Dale AM, Schork NJ: A geographic cline of skull and brain morphology among individuals of European ancestry. Human Heredity, 72:35-44, 2011.
PMC3171282  View
2011
Bonner-Jackson A, Okonkwo O, Tremont G, and the Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E e2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. American Journal of Geriatric Psychiatry, 20:584-593, 2012.
PMC3188382  View
2011
Bossa M, Zacur E, Olmos S and the ADNI: Statistical analysis of relative pose information of subcortical nuclei: Application on ADNI data. Neurimage.55:999-1008, 2011.
PMC3554790  View
2011
Brown PJ, Devanand DP, Liu X, Caccappolo E, Alzheimer's Disease Neuroimaging Initiative: Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry, 68:617-626, 2011.
PMC3682408  View
2011
Cardoso MJ, Clarkson MJ, Ridgway GR, Modat M, Fox NC, Ourselin S, the Alzheimer's Disease Neuroimaging Initiative: LoAd: A locally adaptive cortical segmentation algorithm. Neuroimage. 56:1386-1397, 2011
PMC3554791  View
2011
Carmichael O, Xie J, Fletcher E, Singh B, Decarli C, Alzheimer's Disease Neuroimaging Initiative: Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume. Neurobiology of Aging, 33:1124.e31-e41, 2012.
PMC3323681  View
2011
Chaing GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR Jr, Weiner MW, Alzheimer's Disease Neuroimaging Initiative: Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology, 259:844-851, 2011.
PMC3099048  View
2011
Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR Jr, Landau SM, Foster NL, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative: Characterizing Alzheimer’s Disease Using a Hypometabolic Convergence Index. Neuroimage, 56:52-60, 2011.
PMC3066300  View
2011
Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Oliveri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F, The Alzheimer's Disease Neuroimaging Initiative: Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage, 58:469-480, 2011.
 
2011
Clark DG, for the Alzheimer's Disease Neuroimaging Initiative: Residual vectors for Alzheimer disease diagnosis and prognostication. Brain and Behavior, 1:142-152, 2011.
PMC3236543  View
2011
Cover KS, van Schijndel RA, van Dijk BW, Redolfi A, Knol DL, Frisoni GB, Barkhof F, Vrenken H, neuGRID, the Alzheimer's Disease Neuroimaging Initiative: Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-Rage MRI scans. Psychiatry Res, 193:182-190, 2011.
 
2011
Cover KS, van Schijndel RA, van Dijk BW, Redolfi A, Knol DL, Frisoni GB, Barkhof F, Vrenken H; neuGRID, Alzheimer's Disease Neuroimaging Initiative: Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans. Psychiatry Research, 193:182-190, 2011.
 
2011
Cruchaga C, Nowotny P, Kauwe JS, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM; Alzheimer's Disease Neuroimaging Initiative: Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Archives of Neurology. 68:1013-9, 2011.
PMC3204798  View
2011
Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, Zhu W, Park M, Jiang T, Jin JS, the Alzheimer's Disease Neuroimaging Initiative: Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One, 6:e21896, 2011.
PMC3140993  View
2011
Cuingnet R, Rosso C, Chupin M, Lehericy S, Dormont D, Bennal H, Samson Y, Colliot O: Spatial regularization of SVM for the detection of diffusion alterations associated with stroke outcome. Med Image Anal, 15(5):729-37, 2011.
 
2011
De Jager PL, Shulman JM, Chibnik LB, Keenan BT, Raj T, Wilson RS, Yu L, Leurgans SE, Tran D, Aubin C, Anderson CD, Biffi A, Corneveaux JJ, Huentelman MJ; Alzheimer's Disease Neuroimaging Initiative, Rosand J, Daly MJ, Myers AJ, Reiman EM, Bennett DA, Evans DA: A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiology of Aging, 33:1017.e1-1017.e15,2012
PMC3307898  View
2011
Devanand DP, Liu X, Brown PJ, Huey ED, Stern Y, Pelton GH: A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease. International Journal of Alzheimer's Disease, 2012: 1-8, 2012.
PMC3296186  View
2011
Dickerson BC, Wolk DA, the Alzheimer's Disease Neuroimaging Initiative: MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology, 78:84-90, 2012
PMC3466670  View
2011
Dickerson BC, Wolk DA; the Alzheimer's Disease Neuroimaging Initiative. Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry. 82:45-51, 2011.
PMC3023235  View
2011
Donohue MC, Gamst AC, Thomas RG, Xu R, Beckett L, Petersen RC, Weiner MW, Aisen P; for the Alzheimer's Disease Neuroimaging Initiative. The relative efficiency of time-to-threshold and rate of change in longitudinal data. Contemp Clin Trials.32:685-693, 2011.
PMC3148349  View
2011
Dukart J, Mueller K, Horstmann A, Barthel H, Mooler HE, Villringer A, Sabri O, Schroeter ML: Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.PLoS One, 6:e18111, 2011.
PMC3063183  View
2011
Dukart J, Mueller K, Villringer A, Kherif F, Draganski B, Frackowiak R, Schroeter ML; Alzheimer's Disease Neuroimaging Initiative: Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease. Neuroimage Clinical, 3:84:94, 2013.
PMC3791277  View
2011
Dukart J, Schroeter ML, Mueller K, The Alzheimer's Disease Neuroimaging Initiative: Age correction in dementia - Matching to a healthy brain. PLoS One, 6:e22193, 2011.
PMC3146486  View
2011
Erten-Lyons D, Wilmot B, Anur P, McWeeney S, Westaway SK, Silbert L, Kramer P, Kaye J: Microcephaly genes and risk of late onset Alzheimer Disease. Alzheimer Dis Assoc Disord. 25:276-282, 2011.
PMC3136560  View
2011
Filipovych R, Davatzikos C for the ADNI: Semi-supervised pattern classification of medical images: Application to mild cognitive impairment (MCI). Neuroimage. 55:1109-1119, 2011.
PMC3049826  View
2011
Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J, Wahlund LO, Loszewska I, Mecocci P, Soinnen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S: Genome wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer’s disease. Molecular Psychiatry. 16: 1130-1138, 2011.
 
2011
Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; for the Alzheimer's Disease Neuroimaging Initiative: Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of General Psychiatry, 68: 961-969, 2011.
 
2011
Heckemann RA, Keihaninejad S, Aljabar P, Gray KR, Neilsen C, Rueckert D, Hajnal JV, Hammers A, the ADNI: Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage, 56:2024-2037, 2011.
PMC3153069  View
2011
Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK; For the Alzheimer's Disease Neuroimaging Initiative: Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology, 77: 1619-1628, 2011.
PMC3198979  View
2011
Herholz K, Westwood S, Haense C and Dunn G: Evaluation of a calibrated F-FDG PET score as a biomarker for progression in Alzheimer disease and Mild Cognitive Impairment. Journal of Nuclear Medicine, 52:1218-1226, 2011.
 
2011
Hibar DP, Stein JL, Kohannim O, Jahanshad N, Saykin AJ, Shen L, Kim S, Pankratz N, Foroud T, Huentelman MJ, Potkin SG, Jack CR Jr, Weiner MW, Toga AW, Thompson PM, the Alzheimer’s Disease Neuroimaging initiative. Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects. Neuroimage. 56:1875-1891, 2011.
PMC3366726  View
2011
Hibar DP, Stein JL, Ryles AB, Kohannim O, Jahanshad N, Medland SE, Hansell NK, McMahon KL, deZubicaray GI, Montgomery GW, Martin NG, Wright MJ, Saykin AJ, Jack CR Jr, Weiner MW, Toga AW, Thompson PM, the Alzheimer's Disease Neuroimaging Initiative: Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N=1345 young and elderly subjects. Brain Imaging and Behavior, 7:102-115, 2013.
PMC3779070  View
2011
Hinrichs C, Singh V, Xu G, Johnson SC, The ADNI: Predicitve markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population. Neuroimage. 55:574-589, 2010.
PMC3035743  View
2011
Holland D, Dales A and the ADNI: Nonlinear Registration of Longitudinal Images and Measurement of Change in Regions of Interest. Medical Image Analysis.4:489-497, 2011.
PMC3115407  View
2011
Holland D, McEvoy LK, Dale AM, the Alzheimer's Disease Neuroimaging Initiative: Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. Human Brain Mapping, 33:2586-2602, 2012.
PMC3782292  View
2011
Hu X, Pickering E, Liu YC, Hall S, Fournier H, Dechairo B, John S, Van Eerdewegh PV, Soares H, the ADNI: Meta-analysis for Genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer’s disease. PLOS ONe. 6: e16616, 2011.
PMC3044719  View
2011
Hua X, Gutman B, Boyle CP, Rajagopalan P, Leow AD, Yanovsky I, Kumar AR, Toga AW, Jack CR Jr., Schuff N, Alexander GE, Chen K, Reiman EM, Weiner MW, Thompson PM, the Alzheimer's Disease Neuroimaging Initiative: Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry. Neuroimage. 57:5-14, 2011.
PMC3115407  View
2011
Illan IA, Gorriz JM, Ramirez J, Salas-Gonzalez D, Lopez MM, Segovia F, Chaves R, Gomez-Rio M, Puntonet CG, the ADNI: 18F-FDG PET Imaging for computer aided Alzheimer’s diagnosis. Information Sciences. 181: 903-916, 2011.
PMC2994934  View
2011
Jennings JR, Mendelson DN, Muldoon MF, Ryan CM, Gianaros PJ, Raz N, Aisenstein H: Regional grey matter shrinks in hypertensive individuals despide successful lowering of blood pressure. Journal of Human Hypertension, 26:295-305, 2012.
PMC3137674  View
2011
Johnstone D, Milward EA, Berretta R, Moscato P, for the Alzheimer's Disease Neuroimaging Iniative: Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) plasma proteome dataset. PLoS One, 7:e34341, 2012.
PMC3317783  View
2011
Kauwe JSK, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtman DM, Morris JC, ADNI, Goate AM: Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM. Plos One. 6: e15918, 2011.
PMC3036586  View
2011
Kim S, Swaminathan S, Shen L et al.: Genome-wide association study of CSF biomarkers Ab1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 76: 69-79, 2011.
PMC3030225  View
2011
Koikkalainen J, Laotjaonen J, Thurfjell L, Rueckert D, Waldemar G, Soininen H, the Alzheimer's Disease Neuroimaging Initiative. Multi-template tensor-based morphometry: Application to analysis of Alzheimer's disease. Neuroimage, 56, 1134-1144, 2011.
PMC3554792  View
2011
Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS; Alzheimer's Disease Neuroimaging Initiative: Psychosis in Alzheimer's Disease Is Associated With Frontal Metabolic Impairment and Accelerated Decline in Working Memory: Findings From the Alzheimer's Disease Neuroimaging Initiative. The American Journal of Geriatric Psychiatry, March 2013, Epub ahead of print.
 
2011
Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM et al: Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging, 32:1207-1218, 2011.
PMC2891865  View
2011
Lee GJ, Lu PH, Hua X, Lee S, Wu S, Nguyen K, Teng E, Leow AD, Jack Jr. CR, Toga AW, Weiner MW, Bartzokis G, Thompson PM, and the Alzheimer's Disease Neuroimaging Initiative: Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biological Psychiatry, 71:814-821, 2012.
PMC3322258  View
2011
Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S, the ADNI: Brain MAPS: An automated, accurate and robust brain extraction technique using a template library. Neuroimage, 55:1091-1108, 2011.
PMC3554789  View
2011
Li X, Long X, Laurienti P, Wyatt C: Registration of images with varying topology using embedded maps. IEEE Transactions in Medical Imaging. 31:749-765, 2012.
 
2011
Li Y, Wang Y, Wu G, Shi F, Zhou L, Lin W, Shen D, The ADNI: Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features. Neurobiology of Aging. 33:427.e15-30, 2011.
PMC3086988  View
2011
Llano DA, Laforet G, Devanarayan V, ADNI: Derivation of a new ADAS-cog Composite Using Tree-based Multivariate Analysis: Prediction of Conversion From Mild Cognitive Impairment to Alzheimer Diseaes. Alz. Dis. Assoc. Disord. 25:73-84, 2011
 
2011
Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Arch Neurol. Longitudinal Change of Biomarkers in Cognitive Decline. Epub ahead of print, 2011.
 
2011
Lopez M, Ramirez J, Gorriz JM, Alvarez I, Salas-Gonzalez D, Segovia F, Chaves R, Padilla P, Gomez-Rio M, and the ADNI: Principal component analysis-based techniques and supervised classification schemes for the early detection of Alzheimer’s disease. Neurocomputing. 74: 1260-1271, 2011.
 
2011
Lötjönen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, Waldemar G, Soininen H, Rueckert D; The Alzheimer's Disease Neuroimaging Initiative: Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer’s disease. Neuroimage. 56, 185-196, 2011.
PMC3554788  View
2011
Mackin RS, Insel P, Aisen PS, Geda YE, Weiner MW: Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: Relationship to conversion to dementia after 3 years. International Journal of Geriatric Psychiatry, 27:355-363, 2012.
PMC3685477  View
2011
Markiewicz PJ, Matthews JC, Declerck J, Herholz K, for the Alzheimer's Disease Neuroimaging Initiative: Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage, 56:1382-1385, 2011.
PMC3554787  View
2011
Marshal GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA, Alzheimer's Diease Neuroimaing Initiative: Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia, 7:300-308, 2011.
PMC3096844  View
2011
Marshall GA, Olson LE, Frey MT, Maye J, Becker JA, Rentz DM, Sperling RA, Johnson KA, Alzheimer's Disease Neuroimaging Initiative: Instrumental activities of daily living impairment is associated with increased amyloid burden. Dementia and Geratric Cognitive Disorders, 31:443-450, 2011..
PMC3150869  View
2011
Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldermar G, Soininen H, Lotjonen J: A disease state fingerprint for evaluation of Alzheimer's disease. Journal of Alzheimer's Disease, 27: 163-176.
 
2011
Meda SA, Narayanan B, Liu J, Perrone-Bizzozero NI, Stevens MC, Calhoun VD, Glahn DC, Shen L, Risacher SL, Saykin AJ, Pearlson GD: A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort. Neuroimage, 60:1608-1621, 2012.
PMC3312985  View
2011
O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia, for the Texas Alzheimer's Research & Care Consortium, for the Alzheimer's Disease Neuroimaging Initiative: A blood-based screening tool for Alzheimer's disease that spans serum and plasma: Findings from TARC and ADNI. PLoS One, 6:e28092, 2011.
PMC3233542  View
2011
Pachauri D, Hinrichs C, Chung M, Johnson S, Singh V: Topology based Kernels with application to inference problems in Alzheimer's disease. IEEE Trans Med Imaging. 30:1760-70, 2011.
PMC3245735  View
2011
Park H, Seo J and the ADNI: Application of Multidimensional Scaling to Quantify Shape in Alzheimer’s Disease and Its Correlation with Mini Mental State Examination: A Feasibility Study. Journal of Neuroscience Methods. 15: 380-385, 2011.
 
2011
Pelaez-Coca M, Bossa M, Olmos S and the ADNI: Discrimination of AD and normal subjects from MRI: Anatomical versus statistical regions. Neuroscience Letters. 487: 113-117, 2011.
 
2011
Peng Yu, Robert A.Dean, Stephen D.Hall, Yuan Qi, Gopalan Sethuraman, Brian A.Willis, Eric R.Siemers, Ferenc Martenyi, Johannes T.Tauscher, Adam J.Schwarz: "Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combinatination of Biomarkers to Predict Conversion to Dementia." Journal of Alzheimer's Disease 32, 373-385, 2012.
 
2011
Pillai JA, McEvoy LK, Hagler DJ Jr, Holland D, Dale AM, Salmon DP, Galasko D, Fennema-Notestine C, Alzheimer's Disease Neuroimaging Initiative: Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology, 34:925-935, 2012.
PMC3488147  View
2011
Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative: Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatry Res. 194:7-13, 2011
PMC3185127  View
2011
Rajagopalan P, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport. 391-5, 2011.
PMC3192851  View
2011
Reitz C, Tosto G, Mayeux R, Luchsinger JA, the NIA-LOAD/NCRAD Family Study Group and the Alzheimer's Disease Neuroimaging Initiative: Genetic variants in the fat and obesity associated (FTO) gene and risk of Alzheimer's disease: PLoS One, 7:e50354, 2012.
PMC3520931  View
2011
Richard E, Schmand B, Eikelenboom P, Yang SC, LigthartSA, Moll van Charante EP, van Gool WA, for the Alzheimer's Disease Neuroimaging Initiative: Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dementia and Geriatric Cognitive Disorders. 33:204-209, 2012.
 
2011
RY Lo and WJ Jagust, for the Alzheimer's Disease Neuroimaging Initiative: Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology, 78:1376-1382, 2012.
PMC3345787  View
2011
Samanti MN, Farnum M, Lobanov V, Yang E, Raghavan N, DiBernardo A, Narayan V, and the Alzheimer's Disease Neuroimaging Initiative: An improved model for disease progression in subjects from Alzheimer's Disease Neuroimaging Initiative. Journal of Clinical Pharmacology, 52(5): 629-44, 2011.
 
2011
Schmand B, Eikelenboom P, van Gool WA, the Alzheimer's Disease Neuroimaging Initiative: Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts. Journal of the American Geriatric Society, 59:1705-1710, 2011.
 
2011
Schneider LS, Insel PS, Weiner MW and the ADNI: Treatment with Cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neuro. 68: 58-66, 2011.
PMC3259850  View
2011
Schrag A, Schott JM; Alzheimer's Disease Neuroimaging Initiative: What is the clinically relevant change on the ADAS-Cog? Journal of neurology, neurosurgey, and psychiatry, 83:171-173, 2012.
 
2011
Seaman SR, Bartlett JW, White IR: Multiple imputation of missing covariates with non-linear effects and interactions: An evaluation of statistical methods. BMC Medical Research Methodology, 12:46, 2012.
PMC3403931  View
2011
Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ, the Alzheimer's Disease Neuroimaging Initiative: Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol. 5:597-609, 2011.
PMC3175107  View
2011
Shen KK, Fripp J, Mériaudeau F, Chételat G, Salvado O, Bourgeat P; The Alzheimer's Disease Neuroimaging Initiative: Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models. Neuroimage. 59:2155-2166, 2011.
 
2011
Shen L, Kim S, Qi Y, Inlow M, Swaminathan S, Nho K, Wan J, Risacher S, Shaw L, Trojanowski J, Weiner M, Saykin A, ADNI. Identifying neuroimaging and proteomic biomarkers for MCI and AD via the elastic net. MBIA 2011: International Workshop on Multimodal Brain Image Analysis (MBIA), Sept. 18, 2011, Toronto, Canada.
PMC3202963  View
2011
Silver M, Montana G, and the Alzheiemer's Disease Neuroimaging Initiative: Fast identification of biological pathways associated with a quantitative trait using group lasso with overlaps. Statistical applications in genetics molecular biology, 11: 1-43
PMC3491888  View
2011
Silver M, Montana G, Nichols TE, the ADNI: False positives in neuroimaging genetics using voxel-based morphometry data. NeuroImage. 54: 992-1000, 2011.
PMC3063336  View
2011
Skup M, Zhu H, Wang Y, Giovanello KS, Lin JA, Shen D, Shi F, Gao W, Lin W, Fan Y, Zhang H, the Alzheimer's Disease Neuroimaging Initiative: Sex differences in grey matter atrophy patterns among AD and MCI patients: Results from ADNI. Neuroimage. 56:890-906, 2011.
PMC3085726  View
2011
Soininen H, Mattila J, Koikkalainen J, van Gils M, Hviid Simonsen A, Waldemar G, Rueckert D, Thurfjell L, Lötjönen J: Software Tool for Improved Prediction of Alzheimer's Disease. Neuro-degenerative diseases, 10: 149-52, 2011.
PMC3363350  View
2011
Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE, Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology, 258:843-852, 2011.
 
2011
Spiegel R, Berres M, Miserez AR, Monsch AU, the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Res Ther.3:9, 2011.
PMC3226271  View
2011
Stricker NH, Chang YL, Fennema-Notestine C, Delano-Wood L, Salmon DP, Bondi MW, Dale AM, for the Alzheimer's Disease Neuroimaging Initiative: Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease. Neurology, 77:713-721, 2011.
PMC3164395  View
2011
Swaminathan S, Kim S, Shen L, Risacher SL, Foroud T, Pankratz N, Potkin SG, Huentelman MJ, Craig DW, Weiner MW, Saykin AJ, and the Alzheimer's Disease Neuroimaging Initiative: Genomic copy number analysis in Alzheimer's disease and MCI: An ADNI Study. International Journal of Alzheimer's Disease, epub ahead of print, 2011.
PMC3109875  View
2011
Swaminathan S, Shen L, Risacher SL, Yoker KK, West JD, Kim Sungeun, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR Jr, Weiner MW, Sayking AJ, the Alzheimer's Disease Neuroimaging Initative (ADNI): Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, Brain Imaging and Behavior. 6:1-15, 2011.
PMC3256261  View
2011
Thompson WK, Hallmayer J, O'Hara R, Alzheimer's Disease Neuroimaging Initiative: Design considerations for characterizing psychiatric trajectories across the lifespan: Application to effects of APOE e4 on cerebral cortical thickness in Alzheimer's disease. American Journal of Psychiatry, 168:894-903, 2011.
 
2011
Thomson WK, Holland D, the Alzheimer's Disease Neuroimaging Initiative: Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates. Neuroimage, 57:5-14, 2011.
PMC3471806  View
2011
Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR Jr, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM, Alzheimer's Disease Neuroimaging Initiative: Factors affecting AB plasma levels and their utility as biomarkers in ADNI. Acta Neuropathologica, 122:401-413, 2011.
PMC3299300  View
2011
Vidoni ED, Townley RA, Honea RA, Burns JM; Alzheimer's Disease Neuroimaging Initiative: Alzheimer disease biomarkers are associated with body mass index. Neurology, 77:1913-20, 2011.
PMC3233188  View
2011
Wang H, Nie F, Huang H, Kim S, Nho K, Risacher SL, Sayking AJ, Shen L, for the Alzheimer's Disease Neuroimaigng Initiative: Identifying quantitative trait loci via group-sparse multi-task regression and feature selection: An imaging genetics study of the ADNI cohort. Bioinformatics, 28:229-237, 2012
PMC3259438  View
2011
Wang H, Nie F, Huang H, Risacher SL, Ding C, Saykin AJ, Shen L. A new sparse multi-task regression and feature selection method to identify brain imaging predictors for memory performance. ICCV 2011: IEEE Conference on Computer Vision, November 6-13 2011, Barcelona, Spain.
 
2011
Wang H, Suh JW, Das S, Pluta J, Altinay M, Yushkevich P: Regression-Based Label Fusion for Multi-Atlas Segmentation. Conference on Computer Vision and Pattern Recognition Workshops, 1113-1120, 2011.
PMC3343877  View
2011
Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO, for the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative: AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classifiation accuracy in Europe and North America. Neuroimage, 58:818-828, 2011.
 
2011
Wolk DA, Dickerson BC, ADNI: Fractionating verbal episodic memory in Alzheimer's disease. Neuroimage, 54:1530-1539, 2011
PMC2997155  View
2011
Wolz R, Aljabar P, Hajnal JV, Lotjonen J, Rueckert D, The Alzheimer's Disease Neuroimaging Initiative: Nonlinear dimensionality reduction combining MR imaging with non-imaging information. Medical Image Analysis, 16:819-830, 2012
 
2011
Wolz, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, Soininen H, Lotjonen J, Alzheimer's Disease Neuroimaging Initiative: Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One, 6:e25446, 2011.
PMC3192759  View
2011
Yang W, Lui RL, Gao JH, Chan TF, Yau ST, Sperling RA, Huang X: Independent component analysis-based classification of Alzheimer's disease MRI data, Journal of Alzheimer's Disease, 24:775-785, 2011
PMC3697832  View
2011
Ye J, Farnum M, Yang E, Verbeeck R, Lobanov V, Raghavan N, Novak G, Dibernardo A, Narayan VA: Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data. BMC Neurology, 12:46, 2012.
PMC3477025  View
2011
Yesavage JA, Noda A, Hernandez B, Friedman L, Cheng JJ, Tinkleberg JR, Hallmayer J, O'hara R, David R, Robert P, Landsverk E, Zeitzer JM, the Alzheimer's Disease Neuroimaging Initiative: Cicadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer's disease. American Journal of Geriatric Psychiatry, 19:635-643, 2011
PMC3128424  View
2011
Zhang D, Shen D, Alzheimer's Disease Neuroimaging Initiative: Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One, 7:e33182, 2012
PMC33100854 
2011
Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K, Alzheimer's Disease Neuroimaging Initiative: An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: A follow-up study. Journal of Alzheimer's Disease. Supplement 3:359-367, 2011.
 
2011
Zhang T, Davatzikos C: ODVBA: Optimally-discriminiative voxel-based analysis. IEEE Trans Med Imaging, 30:1441-1454, 2011.
PMC3402713  View
2010
Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, Mathis CA, Weiner MW, Thompson PM, the ADNI: 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging. 31: 1284-1303, 2010.
PMC3051831  View
2010
Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, Zhang H, Kuo JH; Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimers Dement. May; 6(3):257-64, 2010.
PMC2867839  View
2010
Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, Schmansky N, Salat D, Rosan J, for the ADNI: Genetic Variation and Neuroimaging Measures in Alzheimer disease. Archives in Neurology. 67: 677-685, 2010.
PMC2956757  View
2010
Bossa M, Zacur E, Olmos S, Alzheimer's Disease Neuroimaging Initiative. Tensor-based morphometry with stationary velocity field diffeomorphic registration: Application to ADNI. Neuroimage, Jul 51(3):956-69, 2010.
PMC3068621  View
2010
Cairns NJ, Taylor-Reinwald L, Morris JC; Alzheimer's Disease Neuroimaging Initiative. Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. Alzheimers Dement. 2010 May; 6(3):274-9.
PMC2893399  View
2010
Carmicahel O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR, Weiner M, DeCarli C, and the ADNI: Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer Disease Neuroimaging Initiative. Archives of Neurology. 67: 1370-1378, 2010.
PMC3082636  View
2010
Caroli A, Frisoni GB, The ADNI: The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Inititative cohort. Neurobiology of Aging. 31: 1263-1274, 2010.
PMC3467365  View
2010
Casanova R, Wagner B, Whitlow CT, Williamson JD, Shumaker SA, Maldjian JA, Espeland MA: High dimensional classification of structural MRI Alzheimer's disease data based on large scale regularization. Frontiers in Neuroinformatics, 5:1-9, 2011.
PMC3193072  View
2010
Chang Y-L, Bondi MW, Fennema-Notestine C, McEvoy LK, Hagler DJ, Jacobson MW, Dale AM, the Alzheimer’s Disease Neuroimaging Initiative: Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer’s disease. Neuropsychologia, 48: 1237-1247, 2010.
PMC2851550  View
2010
Chang YL, Jacobson MW, Fennema-Notestine C, Hagler DJ, Jennings RG et al: Level of executive function influences verbal memory in amnestic mild congnitive impairment and predicts prefrontal and posterior thickness. Cereb Cortex, 20: 1305-1313, 2010.
PMC2912652  View
2010
Chen K, Langbaum JBS, Fleisher AS, Ayutyanot N, Rescke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, deLeon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM, and ADNI: Twelve-month metabolic declines in probably Alzheimer’s disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region of interest: Findings from the Alzheimer’s Disease Neuroimaging Initiative. Neuroimage, 51: 654-664, 2010.
PMC2856742  View
2010
Chen W, Song X, Zhang Y, Darvesh S, Ningnannan Z, D'Arcy R, Black S, Rockwood K: An MRI-Based Semiquantitative Index for the Evaluation of Brain Atrophy and Lesions in Alzheimer’s Disease, Mild Cognitive Impairment and Normal Aging. Dement. And Geri Cog Disord. 30: 121-130, 2010.
PMC2969164  View
2010
Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptensetang ST, Jack CR, Aisen PS, Petersen RC, Weiner MD, and the ADNI: Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normals. Neurology. 75: 1976-1981, 2010.
PMC3014234  View
2010
Chou YY, Lepore N, Saharan P, Madsen SK, Hua X, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM, and the ADNI: Ventricular maps in 804 ADNI subjects: Correlations with CSF biomarkers and clinical decline. Neurobiology of Aging. 31: 1386-1400, 2010.
PMC2904619  View
2010
Cronk BB, Johnson DK, Burns JM, and the Alzheimer’s Disease Neuroimaging Initiative: Body Mass Index and Cognitive Decline in Mild Cognitive Impairment. Alzheimer’s Disease & Associated Disorders, 24: 126-130, 2010.
PMC3068614  View
2010
Cuingnet R, Chupin M, Benali H, Colliot O: Spatial prior in SVM-based classification of brain images. SPIE. 7624: 76241L-76241L-9, 2010.
 
2010
Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehericy S, Habert MO, Chupin M, Benali H, Colliot O, and the ADNI: Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of then methods using the ADNI database. Neuroimage. 56(2):766-781. 2010.
 
2010
De Meyer G, Shapior F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ, the ADNI: Diagnosis-Independent Alzheimer disease biomarker signature in cognitively normal elderly people. Archives of Neurology, 67: 949-956, 2010.
PMC2963067  View
2010
Desikan RS, Sabuncu MR, Schmansky NJ, Reuter M, Cabral HJ, Hess CP, Weiner MW, Biffi A,Anderson CD, Rosand J, Salat DH, Kemper TL, Dale AM, Sperling RA, Fischl B; Selective disruptive of the cerebral neocortex in Alzheimer's disease. Plos One. 2010.
PMC2944799  View
2010
Epstein NU, Saykin AJ, Risacher SL, Gao S, Farlow MR; Alzheimer's Disease Neuroimaging Initiative (ADNI). Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics. Drugs Aging. 2010 Aug 1;27(8):677-86.
PMC2951125  View
2010
Epstein NU, Saykin AJ, Riscacher SL, Gao S, Farlow MR, and the ADNI: Differences in baseline medication use in the Alzheimer Disease Neuroimaging Study: Analysis of baseline characteristics. Drugs Aging. 27: 677-686, 2010.
PMC2951125  View
2010
Evans MC, Barnes J, Nielson C, Kim, L Clegg SL et al: Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations. Eur Radiol, 71: 441-447, 2009.
 
2010
Fan M, Liu B, Zhou Y, Zhen X, Xu C, Jiang T, and the ADNI: Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults. Neuroscience Letters. 479: 332-336, 2010.
PMC2954463  View
2010
Fjell A, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Hollan D, Brewer JB, Dale AM: CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer’s disease: The Journal of Neuroscience, 30: 2088-2101, 2010.
PMC2828879  View
2010
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ et al: Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. Cerebral Cortex, 20: 2069-2079, 2010.
PMC3025722  View
2010
Fjell AM, Westlye LT, Espeseth T, Reinvang I, Dale AM, Holland D, Walhovd KB: Cortical gray matter atrophy in healthy aging connot be explained by undetected incipient cognitive disorders: A comment on Burgmans et al. Journal of Neuropsychology, 24: 258-263, 2010.
PMC3068612  View
2010
Franke K, Ziegler G, Klöppel S, Gaser C, and the Alzheimer’s Disease Neuroimaging Initiative: Estimating the age of healthy subjects from weighted MRI scans using kernel methods: Exploring the influence of various parameters. NeuroImage,50: 883-892, 2010.
 
2010
Greene SJ, Killiany RJ, The ADNI: Subregions of the inferiro parietal lobule are affected in the progression to Alzheimer's disease. Neurobiology of Aging. 31: 1304-1311, 2010.
PMC2907057  View
2010
Habeck C, Stern Y, ADNI: Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys. 58: 53-67, 2010.
PMC3001346  View
2010
Habeck C.G. Basics of Multivariate Analysis of Neuroimaging Data. J Vis Exp. (41). pii: 1988. doi: 10.3791/1988, 2010
PMC3074457  View
2010
Han M, Schellenberg G, and Wang L: Genome-wide association reveals genetic effects on human Ab42 and τ protein levels in cerebrospinal fluids: a case control study. BMC Neurolog, 10: 1-14, 2010.
PMC2964649  View
2010
Ho AJ, Hua X, Lee S, Leow A, Yanovsky I et al: Comparing 3 Tesla and 1.5 Tesla MRI for Tracking Alzheimer’s Disease Progression with Tensor-Based Morphometry. Human Brain Mapping, 31: 499-514, 2010.
PMC2875376  View
2010
Ho AJ, Raji CA, Becker JT, Lopez OL, Kuller LH, Hua X, Lee S, Hibar D, Dinov ID, Stein JL, Jack CR, Weiner MW, Toga AW, Thompson PM, the Cardiovascular Health Study, and the ADNI: Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiology of Aging. 31: 1326-1339, 2010.
PMC3197833  View
2010
Ho AJ, Stein JL, Hua X, Lee S, Hibar DP…. and the Alzheimer’s Disease Neuroimaging Initiative: A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. PNAS. 107: 8404-8409, 2010.
PMC2889537  View
2010
Hua X, Hibar DP, Lee S, Toga AW, Jack CR, Weiner MW, Thompson PM, and the ADNI: Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiology of Aging. 31: 1463-1480, 2010.
PMC2927200  View
2010
Hua X, Hibar DP, Lee S, Toga AW, Jack CR, Weiner MW, Thompson PM, and the ADNI: Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiology of Aging. 31: 1463-1480, 2010.
PMC2927200  View
2010
Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM, and the ADNI: Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter scan intervals. Neuroimage. 51: 63-75, 2010.
PMC2846999  View
2010
Huang S, Li J, Sun L, Ye J, Fleisher A, Wu T, Chen K, Reiman E, Alzheimer's Disease Neuroimaging Initiative: Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation. Neuroimage, 50:935-949, 2010.
PMC3068623  View
2010
Ito K, Ahadleh S, Corrigan B, French J, Fullerton T et al: Disease Progression Meta-Analysis Model in Alzheimer’s Disease. Alz and Dement, 6: 39-53, 2010.
 
2010
Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA, and the ADNI: The Alzhimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia. 6: 221-229, 2010.
PMC2920531  View
2010
Jun G, Naj AC, Beecham GW, Wang LS, Buros J…. et al: Meta-Analysis confirms CR1, CLU, and PICALM as Alzheimer’s disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 67: 1473-1484, 2010.
PMC3048805  View
2010
Karow DS, McEvoy L, Fennema-Notestine C, Hagler DJ, Jennings RG, Brewer JB, Hoh CK, Dale AM and the ADNI: Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology. 256:932-942, 2010
PMC2923729  View
2010
Kauwe JS, Cruchaga C, Bertelsen S, Mayo K, Latu W, Notwotny P, Hinrichs AL, Fagan AM, Holtzman DM ADNI, Goate AM: Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels. J Alzheimers Dis., 21: 833-842, 2010.
PMC3032214  View
2010
Kauwe JSS, Bertelson S, Cruchaga C, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S, Morris JC, Goate AM, and the ADNI: Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. American Journal of Medical Genetics. 153B: 955-959, 2010.
PMC2877151  View
2010
King RD, Brown B, Hwang M, Jeon T, George AT, and the ADNI: Fractal dimension analysis of the cortical ribbon in mild Alzheimer's disease. NeuroImage. 52: 471-479, 2010.
PMC2942777  View
2010
Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR, Weiner MW, Thompson PM, and the ADNI: Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiology of Aging. 31: 1429-1442, 2010.
PMC2903199  View
2010
Kruggel F, Turner J, Muftuler LT: Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. NeuroImage, 49: 2123-2133, 2010.
PMC2951115  View
2010
Landau SM, Harvey D, Madison CM, Reiman EM, Foster NLS, Aisen PS, Petersen RC, Shaw LM, Torjanowski JQ, Jack Jr. CR, Weiner MW, Jagust WJ, and the ADNI: Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 75: 230, 2010.
PMC2906178  View
2010
Lemoine B, Rayburn S, Benton R: Data fusion and feature selection for Alzheimer's disease. Lec Notes in Comp Sci. 6334: 320-327, 2010.
 
2010
Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S, ADNI: Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer’s disease. Neuroimage, 51: 1345-1359, 2010.
PMC2873209  View
2010
Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR, Weiner MW, Fox NC, Ourselin S, and the Alzheimer’s Disease Neuroimaging Initiative: Robust atrophy rate measurement in Alzheimer’s disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection. NeuroImage, 50: 516-523, 2010.
PMC2828361  View
2010
Lötjönen JMP, Wolz R, Koikkalainen JR, Thurfjell L, Waldemar G, Soininen H, Rueckert D, and the Alzheimer’s Disease Neuroimaging Initiative: Fast and robust multi-atlas segmentation of brain magnetic resonance images. NeuroImage, 49:2352-2365, 2010.
 
2010
Madsen SK, Ho AJ, Saharan PS, Toga AW, Jack CR, Weiner MW, Thompson PM, The ADNI: 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiology of Aging. 31: 1312-1325, 2010.
PMC2903198  View
2010
McDonald CR, Gharapetian L, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, Holland D, Dale AM; Alzheimer's Disease Neuroimaging Initiative. Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiol Aging: 33:242-253, 2012
PMC2923665  View
2010
McEvoy LK, Edland SD, Hollan D, Hagler DJ, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM, for the ADNI: Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. Alz Dis & Assoc Dis. 24: 269-277, 2010.
PMC2929320  View
2010
Murphy EA, Holland D, Donohue M, McEvoy LK, Hagler DJ, Dale AM, Brewer JB and the ADNI: Six-Month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. NeuroImage. 53: 1310-1317, 2010.
PMC2939234  View
2010
Nettiksimmons J, Harvey D, Brewer J, Carmichael O, DeCarli C, Jack CR, Petersen R, Shaw LM, Trojanowski JQ, Weiner MW, Beckett L: Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiology on Aging. 31: 1419-1428, 2010.
PMC2902683  View
2010
Okonkow OC, Alosco ML, Jerskey BA, Sweet LH, Orr BR, Tremont G, and the ADNI: Cerebral atrophy, apolipoprotein E 4, and the rate of decline in everyday function among patients with amnestic mild cognitive impairment. Alzheimer's & Dementia. 6: 404-411, 2010.
PMC2950092  View
2010
Okonkwo OC, Alosco ML, Griffith HR, Mielke MM, Shaw LM, Trojanowski JQ, Tremont G, ADNI: Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum. Archives of Neurology. 67: 688-696, 2010.
PMC2888499  View
2010
Ott BR, Cohen RA, Gongvatana A, Okonkwo OC, Johanson CE, Stopa EG, Donahue JE, Silverberg GD, and the ADNI: Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease. Journal of Alzheimer's Disease. 20: 1387-2877, 2010.
PMC3078034  View
2010
Rimol LM, Agartz I, Djurovic S, Brown AA, Roddey JC et al: Sex-Dependent Association of Common Variants of Microcephaly Genes with Brain Structure. PNAS, 107: 384-388, 2010.
PMC2806758  View
2010
Risacher, SL, Shen L, West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR, Weiner MW, Saykin AJ: Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort. Neurobiology of Aging. 31: 1401-1418, 2010.
PMC2904350  View
2010
Rousseau F, ADNI: A non-local approach for image super-resolution using intermodality priors. Med Image Anal. 14: 594-605, 2010.
PMC2947386  View
2010
Salas-Gonzalez D, Gorriz JM, Ramirez J, Illan IA, Lopez M, Segovia F, Chaves R and Padilla P: Feature selection using factor analysis for Alzheimer’s diagnosis using F-FDG PET images. Medical Physics. 37: 6084-6095, 2010.
PMC2994934  View
2010
Saykin, AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Kwangsik N, Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR, Weiner MW, and the ADNI: Alzheimer's Disease Neuroimaging biomarkers as quatitative phenotypes: Genetics core aims, progress, and plans. Alzheimer's & Dementia. 6: 265-273, 2010.
PMC2868595  View
2010
Schneider LS, Kennedy RE, Cutter GR and ADNI: Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer disease or mild cognitive impairment does not lead to more efficient clinical trials. Alzheimer's and Dementia. 6: 367-377, 2010.
PMC2947209  View
2010
Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators. Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging. Aug; 31(8):1452-1462, 2010.
PMC2947486  View
2010
Schott JM, Bartlett JW, Fox NC, Barnes J and the ADNI: Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Annals of Neurology. 68: 825-834, 2010.
 
2010
Schuff N, Tosun D, Insel PS, Chiang GC, Truran D, Aisen PS, Jack CR, Weiner MW, the ADNI: Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiology of Aging. 33:845-855, 2012.
PMC3032014  View
2010
Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR, Weiner MW, the ADNI: MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. BRAIN. 132: 1067-1077, 2010.
PMC2668943  View
2010
Shen L, Kim S, Risacher S, Nho K, Waminathan S et al: Whole Genome Association Study of Brain-Wide Imaging Phenotypes for Identifying Quantitative Trait Loci in MCI and AD: A Study of the ADNI Cohort. NeuroImage, 53: 1051-1063, 2010.
PMC2892122  View
2010
Shen L, Qi Y, Kim S, Nho K, Wan J, Risacher SL, Saykin AJ; ADNI. Sparse bayesian learning for identifying imaging biomarkers in AD prediction. Med Image Comput Comput Assist Interv. 2010a;13(Pt 3):611-8.
PMC2951627  View
2010
Stein JL, Hibar DP, Madsen SK, Khamis M, McMahon KL, de Zubicaray GI, Hansel NK, Montgomery GW, Matin NG, Wright MJ, Saykin AJ, Jack CR, Jr., Weiner MW, Toga AW, Thompson PM: Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search. Mol Psych. 16:927-937, 2011.
PMC3140560  View
2010
Stein JL, Hua X, Lee S, Ho A, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, DeChairo BM, Potkin SG, Weiner MW, Thompson PM, ADNI: Voxelwise genome-wide association study (vGWAS). Neuroimage, 15: 1160-1174, 2010.
PMC2900429  View
2010
Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Faroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin SG, Jack CJ, Jr., Weiner MW, Thompson PM, and the ADNI: Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage. 51: 542-554, 2010.
PMC2856746  View
2010
Stonnington CM, Chu C, Kloppel S, Jack CR Jr, Ashburner J, Frackowiak RS, the ADNI: Predicting clinical scores from magnetic resonance scans in Alzheimer’s disease. Neuroimage, 51: 1405-1413, 2010.
PMC2871976  View
2010
Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW, and the ADNI: Relations between brain tissue loss, CSF biomarkers, and the APOE genetic profile: A longitudinal MRI study. Neurobiology of Aging. 31: 1340-1354, 2010.
PMC2902689  View
2010
Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR, Jagust W, Toga AW< Lee VM, Shaw LM, and the ADNI: Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's & Dementia. 6: 230-238, 2010.
PMC2867838  View
2010
Vounou M, Nichols TE, Montana G, and the ADNI: Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach. NeuroImage. 15: 1147-1159, 2010.
 
2010
Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Karow D, Dale AM, and the ADNI: Combining MRI, PET and CSF biomarkers in diagnosis and prognosis of Alzheimer's disease. American Journal of Neuroradiology. 31: 347-354, 2010.
PMC2821467  View
2010
Walhovd, KB, Fjell AM, Dale AM, McEvoy LK, Brewer J, Karow DS, Salmon DP, Fennema-Notestine C, the ADNI: Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiology of Aging. 31: 1107-1121, 2010.
 
2010
Wang H, Das S,Pluta J, Craige C, Altinay M, Avants B, Weiner M, Mueller S, Yushkevich P: Standing on the shoulders of giants: Improving medical image segmentation via learning based bias correction. Med Image Comput Assist Interv. 13: 105-112, 2010.
PMC3095022  View
2010
Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green RC, Walter S, Soares H, Snyder P, Siemens E, Potter W, Cole PE, Schmidt M, and the ADNI: The Alzhiemer's Disease Neurimaging Initiative: Progress report and future plans. Alzheimer's & Dementia. 6: 202-211, 2010.
PMC2927112  View
2010
Wolk DA, Dickerson BC, and the Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network fucntion in Alzheimer's disease. PNAS 107: 10256-10261, 2010.
PMC2890481  View
2010
Wolz R, Aljabar P, Hajnal JV, Hammers A, Rueckert D, and the Alzheimer’s Disease Neuroimaging Initiative: LEAP: Learning embeddings for atlas propogation. NeuroImage, 49:1316-1325, 2010.
PMC3068618  View
2010
Wolz R, Heckemann RA, Alijabar P, Hajnal JV, Hammers A, Lotjonen J, Rueckert D, and the ADNI: Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI. Neuroimage. 52: 109-118, 2010.
 
2010
Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe EM, the ADNI: Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. Journal of Neuroscience Methods. 192: 277-285, 2010.
PMC2952503  View
2010
Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T, ADNI: Effects of BDNF val66met polymorphism on brain metabolism. Molecular Neuroscience., 21: 802-807, 2010.
PMC2954459  View
2010
Yang W, Chen X, Hong X, and Huang X: ICA-Based automatic classification of magnetic resonance images from ADNI data. Lecture Notes in Computer Science. 6330: 340-347, 2010.
 
2010
Yushkevich PA, Avants BB, Das SR, Pluta J, Altinay M et al: Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global mormalization: An illustration in ADNI 3 T MRI data. NeuroImage, 50: 434-445, 2010.
PMC2823935  View
2010
Zhang T, Davatzikos C: Optimally-Discriminative Voxel-Based Analysis. Lecture Notes in Computer Science. 6362: 257-265, 2010.
 
2009
Acosta O, Bourgeat P, Zuluaga MA, Fripp J, Salvado O, Ourselin S, and ADNI: Automated voxel-based 3D cortical thickness measurement in a combined Lagrangian-Eulerian PDE approach using partial volume maps. Medical Image Analysis. 12: 730-743, 2009.
PMC306813 
2009
Bauer CM, Jara H, Killiany R and ADNI: Whole brain T2 MRI across multiple scanners with dual echo FSE: Applications to AD, MCI, and normal aging. Neuroimage 52: 508-514, 2009.
PMC2907072  View
2009
Brewer JB, Magda S, Airriess C, Smith ME: Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. American J of Neuroradiology. 3: 578-580. 2009.
PMC2688740  View
2009
Buerger K, Frisoni G, Uspenskaya O, Ewers M, Zetterberg H, Geroldi C, Binetti G, Johannsen P, Rossini PM, Wahlund LO, Vellas B, Blennow K, Hampel H: Validation of Alzheimer's disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Experimental Gerontology. 44: 579-585, 2009.
PMC2657833  View
2009
Calvini P, Chincarini A, Gemme G, Penco MA, Squarcla S et al: Automatic analysis of Medial Temporal Lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Medical Physics, 36: 3737-3747, 2009.
PMC2724178  View
2009
Chou YY, Lepore N, Avedissian C, Madsen SK, parishak N, Hua X, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM, and ADNI: Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage.46: 394-410, 2009.
PMC2696357  View
2009
Chupin M, Gerardin E, Cuingnet R, Boutet C, Lemieux L, Lehericy S, Benal H, Garnero L, Colliot O, and the ADNI: Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus. 19: 579-587, 2009.
PMC2837195  View
2009
Cruchaga C, Kauwe JS, Bertelsen S, Nowotny P, Shah AR et al: SNPs in the regulatory subunit of calcineurin are associated with CSF tau protein levels, brain mRNA levels. Alzheimer’s and Dementia, 5: 471-472, 2009.
PMC2940763  View
2009
Fennema-Notestine C, Hagler DJ, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM, and ADNI: Structural Biomarkers for precilnical and mild Alzheimer's disease. Human Brain Mapping, 30: 3238-3253, 2009.
PMC2951116  View
2009
Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM: One-Year Brain Atrophy Evident in Healthy Aging. The Journal of Neuroscience, 29(48):15223-15231, 2009.
PMC2827793  View
2009
Fleisher AS, Donahue M, Chen K, Brewer JB, Aisen PS, the Alzheimer’s Disease Neuroimaging Initiative: Applications of neuroimaging to disease-modification trials in Alzheimer’s disease. Behavioural Neurology, 21:129-136, 2009.
 
2009
Gunter JL, Berstein MA, Borowski BJ, Ward CP, Britson PJ, Felmlee JP, Schuff N, Weiner MW, Jack CR: Measurement of MRI performance with the ADNI phantom. Meds. Phys. 36: 2193, 2009.
PMC2754942  View
2009
Haense C, Herholz K, Jagust WJ, Heiss WD: Performance of FDG PET for detection of Alzheimer’s disease in two independent multicentre samples (NEST-DD and ADNI). Dement and Geriatric Cogn Disord, 28: 259-266, 2009.
 
2009
Hinrichs C, Sing V, Mukherjee L, Xu G, Chung MK, Johnson SC, and the Alzheimer’s Disease Neuroimagin Initiative: Spatially augmented LP boosting for AD classification with evaluations on the ADNI dataset. NeuroImage, 48:138-149, 2009.
PMC2773131  View
2009
Holland D, Brewer JB, Hagler DJ, Fenema-Nostestine C, Dale AM, and the ADNI: Subregional neuroanatomical change as a biomarker for Alzheimer's disease. PNAS. 106: 20954-20959, 2009.
PMC2791580  View
2009
Hua X, Lee S, Yanovsky I, Leow AD, Ho AJ et al: Optimizing Power to Track Brain Degeneration in Alzheimer’s Disease and Mild Cognitive Impairment with Tensor-Based Morphometry: An ADNI Study of 515 Subjects. Neuroimage, 48: 668-681, 2009.
PMC2971697  View
2009
Huang A, Abugharbieh R, Tam R and ADNI, A Hybrid Geometric-Statistical Deformable Model for Automated 3-D Segmentation in Brain MRI. IEEE, 56: 1838-1848, 2009.
PMC3068615  View
2009
Jagust, WJ, Landau, SM, Shaw, LM, Trojanowski, JQ, Koeppe RA, et al: Relationships between biomarkers in aging and dementia. Neurology, 73: 1193-1199, 2009.
PMC2764726  View
2009
Joyner AH, Roddey CJ, Cinnamon SB, Bakken TE, Rimol LM et al: A Common MECP2 Haplotype Associates With Reduced Cortical Surface Area in Two Independent Populations. PNAS, 106: 15483-15488, 2009.
PMC2741277  View
2009
King RD, George AT, Jeon T, Hynan LS, Youn TS, Kennedy DN, Dickerson B, and the Alzheimer’s Disease Neuroimaging Initiative: Characterization of Atrophic Changes in the Cerebral Cortex Using Fractal Dimensional Analysis. Brain Imaging and Behavior, 3:154-166, 2009.
PMC2927230  View
2009
Kovacevic S, Rafii MS, Brewer BJ and the Alzheimer’s Disease Neuroimaging Initiative. High-throughput, Fully-automated Volumetry for Prediction of MMSE and CDR Decline in Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders, 23(2):139-145, 2009.
PMC2688740  View
2009
Langbaum JBS, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM, and ADNI: Categorical and correlational analyses of baseline fluodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). NeuroImage. 45: 1107-1116, 2009.
PMC2886795  View
2009
Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM, and ADNI: Alzheimer's Disease Neuroimaging Initiative: A one-year follow-up study using tensor-based morphometry degenerative rates, biomarkers and cognition. Neuroimage. 45: 645-655, 2009.
PMC2696624  View
2009
McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ, Holland D, Koyama A, Brewer JB, Dale AM, for the Alzheimer’s Disease Neuroimaging Initiative: Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology, 73: 457-465, 2009.
PMC2727145  View
2009
McEvoy L.K., Fennema-Notestine C., Cooper, J.C., Hagler, D. Jr., Holland, D., Karow D.S., Pung, C.J. Brewer J.B., Dale A.M. for the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's Disease: Quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology, 251(1):195-205, 2009.
PMC2663582  View
2009
Misra C, Fan Y, Davatzikos C: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI. Neuroimage. 44: 1415-1422, 2009.
PMC2648825  View
2009
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM and the ADNI: Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage. 45: S3-15, 2009.
PMC2733354  View
2009
Morra JH, Zhuwen T, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM, and ADNI: Automated 3D Mapping of Hippocampal Atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Human Brain Mapping. 30: 2766-2788, 2009.
PMC2733926  View
2009
Morra JH, Zhuwen T, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM, and ADNI: Automated 3D Mapping of Hippocampal Atrophy and its clinical correlates in 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage. 45: S3-S15, 2009.
PMC2733354  View
2009
Qiu A, Fennema-Notestine C, Dale AM, Miller MI. Alzheimer's Disease Neuroimaging Initiative. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. Neuroimage. 45(3):656-61, 2009.
PMC2847795  View
2009
Querbes O, Aubry F, Pariente J, Lotterie J-A, Demonet JF, Duret V, Puel M, Berry I, Fort J-C, Celsis P, ADNI: Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. BRAIN. 132: 2036-2047, 2009.
PMC2714060  View
2009
Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC, and the Alzheimer’s Disease Neuroimaging Initiative: Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort. Current Alzheimer Research, 6:347-361, 2009.
PMC2764863  View
2009
Shaw LM, Vanderstichele H, Knapnik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VMY, Trojanowski JQ and the ADNI: Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Annals of Neurology. 65: 403-413, 2009.
PMC2696350  View
2009
Vemuri P, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC, Jack Jr CR and the Alzheimer’s Disease Neuroimaging Initiative: Serial MRI and CSF biomarkers in normal, MCI and AD. Brain, 132:1355-1365, 2009.
PMC2905929  View
2009
Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ et al: MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology, 73: 294-301, 2009.
PMC2715214  View
2008
Fan Y, Batmanghelich N, Clark CM, Davatzikos C, and ADNI: Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage. 39: 1731-1743, 2008.
PMC2861339  View
2008
Gunter, JL, Borowski B, Britson P, Berstein M, Ward C, Felmlee J, Schuff N, Weiner M, Jack C: Alzheimer's Disease Neuroimaging Initiative phantom and scanner longitudinal performance. Alzheimer's and Dementia. 4: T370, 2008.
 
2008
Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR, Berstein MA, Britson PJ, Ward CP, Whitewell JL, Borowski B, Felsiher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta L, Alexander GE, Weiner MW, Thompson PM, and ADNI: 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensore-based morphometry. Neuroimage. 41: 19-34, 2008.
PMC2556222  View
2008
Hua, X, Leow AD, parishak N, Lee S, Chiang MC, Toga AW, Jack CR, Weiner MW, Thompson PM, and ADNI: Tensor-based morphometry as a neurimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects. Neuroimage. 43: 458-469, 2008.
PMC3197851  View
2008
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM, the Alzheimer’s Disease Neuroimaging Initiative. Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer’s disease mild cognitive impairment , and elderly controls. Neuroimage, 43(1): 59-68, 2008.
PMC2624575  View
2008
Mueller SG, Weiner MW, Thal LJ, Peterson RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L: Alzheimer's Disease Neuroimaging Initiative. Advances in Alzheimer's and Parkinson's Disease. 183-189, 2008.
PMC2376747  View
2008
Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R, and the ADNI: Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 131: 2443-2454, 2008.
PMC2724905  View
2008
Tsolaki MN, Papaliagkas VT, Jones R, Touchon J, Spiru L, Visser PJ, Verhey F, and DESCRIPA Study Group: Medication in patients with mild cognitive impairment in Europe: The development of screening guidelines and clinical criteria of predementia Alzheimer's disease (DESCRIPA) study. Alzheimer's and Dementia. 4: T683-T684, 2008.
PMC2821431  View
2006
Leow AD, Klunder AD, Jack CR, Jr., Toga AW, Dale AM, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Whitwell JL, Borowski BJ, Fleisher AS, Fox NC, Harvey D, Kornak J, Schuff N, Studholme C, Alexander GE, Weiner MW, Thompson PM, for the ADNI Prepatory Phase Study: Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. NeuroImage. 31: 627-640, 2006.
PMC1941663  View
2005
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Becket L: Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI), Alzheimer's Dementia, 1: 55-66, 2005.
PMC1864941  View
Questions for the DPC may be emailed directly to Erin Drake.

If you have prepared a manuscript utilizing ADNI data, please submit it for review by the ADNI DPC before submitting to a journal for peer review and publication, by emailing it to Erin Drake.